Eurlexa

English
- Sign in
- Register

Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

Modified by

Commission Regulation (EEC) No 675/92of 18 March 1992amending Annexes I and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 392R0675, March 19, 1992
Commission Regulation (EEC) No 762/92of 27 March 1992modifying Annex V to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 392R0762, March 28, 1992
Commission Regulation (EEC) No 3093/92of 27 October 1992amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 392R3093, October 28, 1992
Commission Regulation (EEC) No 895/93of 16 April 1993amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R0895, April 17, 1993
Council Regulation (EEC) No 2901/93of 18 October 1993amending Annexes I, II, III and IV to Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R2901, October 23, 1993
Commission Regulation (EC) No 3425/93of 14 December 1993amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R3425, December 15, 1993
Commission Regulation (EC) No 3426/93of 14 December 1993amending Annexes III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R3426, December 15, 1993
Commission Regulation (EC) No 955/94of 28 April 1994amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 394R0955, April 29, 1994
Commission Regulation (EC) No 1430/94of 22 June 1994amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R1430, June 23, 1994
Commission Regulation (EC) No 2701/94of 7 November 1994amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R2701, November 8, 1994
Commission Regulation (EC) No 2703/94of 7 November 1994amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R2703, November 8, 1994
Commission Regulation (EC) No 3059/94of 15 December 1994amending Annexes I, II, and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R3059, December 16, 1994
Commission Regulation (EC) No 1102/95of 16 May 1995amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R1102, May 17, 1995
Commission Regulation (EC) No 1441/95of 26 June 1995amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R1441, June 27, 1995
Commission Regulation (EC) No 1442/95of 26 June 1995amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities No L 143 of 27 June 1995)Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities No L 143 of 27 June 1995)Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Com munity procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official journal of the European Communities No L 143 of 27 June 1995), 395R1442395R1442R(02)395R1442R(03)395R1442R(04), June 27, 1995
Commission Regulation (EC) No 1798/95of 25 July 1995amending Annex IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1798, July 26, 1995
Commission Regulation (EC) No 2796/95of 4 December 1995amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R2796, December 5, 1995
Commission Regulation (EC) No 2804/95of 5 December 1995amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R2804, December 6, 1995
Commission Regulation (EC) No 281/96of 14 February 1996amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R0281, February 15, 1996
Commission Regulation (EC) No 282/96of 14 February 1996amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R0282, February 15, 1996
Commission Regulation (EC) No 1140/96of 25 June 1996amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R1140, June 26, 1996
Commission Regulation (EC) No 1147/96of 25 June 1996amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R1147, June 26, 1996
Commission Regulation (EC) No 1311/96of 8 July 1996amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R1311, July 9, 1996
Commission Regulation (EC) No 1312/96of 8 July 1996amending Annex III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1312, July 9, 1996
Commission Regulation (EC) No 1433/96of 23 July 1996amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1433, July 24, 1996
Commission Regulation (EC) No 1742/96of 6 September 1996amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1742, September 7, 1996
Commission Regulation (EC) No 1798/96of 17 September 1996amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1798, September 18, 1996
Commission Regulation (EC) No 2010/96of 21 October 1996amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R2010, October 22, 1996
Commission Regulation (EC) No 2017/96of 22 October 1996amending Annex III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R2017, October 23, 1996
Commission Regulation (EC) No 2034/96of 24 October 1996amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R2034, October 25, 1996
Commission Regulation (EC) No 17/97of 8 January 1997amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0017, January 9, 1997
Commission Regulation (EC) No 211/97of 4 February 1997amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R0211, February 5, 1997
Commission Regulation (EC) No 270/97of 14 February 1997amending Annex I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0270, February 15, 1997
Council Regulation (EC) No 434/97of 3 March 1997amending Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0434, March 7, 1997
Commission Regulation (EC) No 716/97of 23 April 1997amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0716, April 24, 1997
Commission Regulation (EC) No 748/97of 25 April 1997amending Annex I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0748, April 26, 1997
Commission Regulation (EC) No 749/97of 25 April 1997amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0749, April 26, 1997
Commission Regulation (EC) No 1836/97of 24 September 1997amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1836, September 25, 1997
Commission Regulation (EC) No 1837/97of 24 September 1997amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1837, September 25, 1997
Commission Regulation (EC) No 1838/97of 24 September 1997amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1838, September 25, 1997
Commission Regulation (EC) No 1850/97of 25 September 1997amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1850, September 26, 1997
Commission Regulation (EC) No 121/98of 16 January 1998amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R0121, January 17, 1998
Commission Regulation (EC) No 426/98of 23 February 1998amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R0426, February 24, 1998
Commission Regulation (EC) No 613/98of 18 March 1998amending Annexes II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R0613, March 19, 1998
Commission Regulation (EC) No 1000/98of 13 May 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1000, May 14, 1998
Commission Regulation (EC) No 1076/98of 27 May 1998amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1076, May 28, 1998
Commission Regulation (EC) No 1191/98of 9 June 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1191, June 10, 1998
Commission Regulation (EC) No 1568/98of 17 July 1998amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 1568/98 of 17 July 1998 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 205 of 22 July 1998), 398R1568398R1568R(01), July 22, 1998
Commission Regulation (EC) No 1569/98of 17 July 1998amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1569, July 22, 1998
Commission Regulation (EC) No 1570/98of 17 July 1998amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1570, July 22, 1998
Commission Regulation (EC) No 1916/98of 9 September 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1916, September 10, 1998
Commission Regulation (EC) No 1917/98of 9 September 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1917, September 10, 1998
Commission Regulation (EC) No 1958/98of 15 September 1998amending Annexes I, II and III of Council Regulation (EEC) No 2377/94 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1958, September 16, 1998
Commission Regulation (EC) No 2560/98of 27 November 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2560, November 28, 1998
Commission Regulation (EC) No 2686/98of 11 December 1998amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2686, December 12, 1998
Commission Regulation (EC) No 2692/98of 14 December 1998amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2692, December 15, 1998
Commission Regulation (EC) No 2728/98 of17 December 1998amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2728, December 18, 1998
Commission Regulation (EC) No 508/1999of 4 March 1999amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 399R0508, March 9, 1999
Commission Regulation (EC) No 804/1999of 16 April 1999amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0804, April 17, 1999
Commission Regulation (EC) No 953/1999of 5 May 1999amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0953, May 6, 1999
Commission Regulation (EC) No 954/1999of 5 May 1999amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0954, May 6, 1999
Commission Regulation (EC) No 997/1999of 11 May 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0997, May 12, 1999
Commission Regulation (EC) No 998/1999of 11 May 1999amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0998, May 12, 1999
Council Regulation (EC) No 1308/1999of 15 June 1999amending Regulation (EC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal originCorrigendum to Council Regulation (EC) No 1308/1999 of 15 June 1999 amending Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 156 of 23 June 1999), 399R1308399R1308R(01), June 23, 1999
Commission Regulation (EC) No 1931/1999of 9 September 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R1931, September 10, 1999
Commission Regulation (EC) No 1942/1999of 10 September 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R1942, September 11, 1999
Commission Regulation (EC) No 1943/1999of 10 September 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R1943, September 11, 1999
Commission Regulation (EC) No 2385/1999of 10 November 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2385, November 11, 1999
Commission Regulation (EC) No 2393/1999of 11 November 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2393, November 12, 1999
Commission Regulation (EC) No 2593/1999of 8 December 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2593, December 9, 1999
Commission Regulation (EC) No 2728/1999of 20 December 1999amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2728, December 22, 1999
Commission Regulation (EC) No 2757/1999of 22 December 1999amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2757, December 23, 1999
Commission Regulation (EC) No 2758/1999of 22 December 1999amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2758, December 23, 1999
Commission Regulation (EC) No 1286/2000of 19 June 2000amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R1286, June 20, 2000
Commission Regulation (EC) No 1295/2000of 20 June 2000amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R1295, June 21, 2000
Commission Regulation (EC) No 1960/2000of 15 September 2000amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R1960, September 16, 2000
Commission Regulation (EC) No 2338/2000of 20 October 2000amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2338, October 21, 2000
Commission Regulation (EC) No 2391/2000of 27 October 2000amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2391, October 28, 2000
Commission Regulation (EC) No 2535/2000of 17 November 2000amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2535, November 18, 2000
Commission Regulation (EC) No 2908/2000of 29 December 2000amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2908, December 30, 2000
Commission Regulation (EC) No 749/2001of 18 April 2001amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R0749, April 19, 2001
Commission Regulation (EC) No 750/2001of 18 April 2001amending Annex II to Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R0750, April 19, 2001
Commission Regulation (EC) No 807/2001of 25 April 2001amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 118 of 27 April 2001), 301R0807301R0807R(01), April 27, 2001
Commission Regulation (EC) No 1274/2001of 27 June 2001amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1274, June 28, 2001
Commission Regulation (EC) No 1322/2001of 29 June 2001amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1322, June 30, 2001
Commission Regulation (EC) No 1478/2001of 18 July 2001amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1478, July 19, 2001
Commission Regulation (EC) No 1553/2001of 30 July 2001amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1553, July 31, 2001
Commission Regulation (EC) No 1680/2001of 22 August 2001amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1680, August 23, 2001
Commission Regulation (EC) No 1815/2001of 14 September 2001amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 246 of 15 September 2001), 301R1815301R1815R(01), September 15, 2001
Commission Regulation (EC) No 1879/2001of 26 September 2001amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1879, September 27, 2001
Commission Regulation (EC) No 2162/2001of 7 November 2001amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R2162, November 8, 2001
Council Regulation (EC) No 2584/2001of 19 December 2001amending Annexes I and III of Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R2584, December 29, 2001
Commission Regulation (EC) No 77/2002of 17 January 2002amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R0077, January 18, 2002
Commission Regulation (EC) No 868/2002of 24 May 2002amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R0868, May 25, 2002
Commission Regulation (EC) No 869/2002of 24 May 2002amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R0869, May 25, 2002
Commission Regulation (EC) No 1181/2002of 1 July 2002amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 172 of 2 July 2002)Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 172 of 2 July 2002)Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 172 of 2 July 2002), 302R1181302R1181R(01)302R1181R(02)302R1181R(03), July 2, 2002
Commission Regulation (EC) No 1530/2002of 27 August 2002amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R1530, August 28, 2002
Commission Regulation (EC) No 1752/2002of 1 October 2002amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R1752, October 2, 2002
Commission Regulation (EC) No 1937/2002of 30 October 2002amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R1937, October 31, 2002
Commission Regulation (EC) No 61/2003of 15 January 2003amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0061, January 16, 2003
Commission Regulation (EC) No 544/2003of 27 March 2003amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0544, March 28, 2003
Commission Regulation (EC) No 665/2003of 11 April 2003amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0665, April 12, 2003
Commission Regulation (EC) No 739/2003of 28 April 2003amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0739, April 29, 2003
Council Regulation (EC) No 806/2003of 14 April 2003adapting to Decision 1999/468/EC the provisions relating to committees which assist the Commission in the exercise of its implementing powers laid down in Council instruments adopted in accordance with the consultation procedure (qualified majority), 303R0806, May 16, 2003
Commission Regulation (EC) No 1029/2003of 16 June 2003amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R1029, June 17, 2003
Commission Regulation (EC) No 1490/2003of 25 August 2003amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R1490, August 26, 2003
Commission Regulation (EC) No 1873/2003of 24 October 2003amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R1873, October 25, 2003
Commission Regulation (EC) No 2011/2003of 14 November 2003amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R2011, November 15, 2003
Commission Regulation (EC) No 2145/2003of 8 December 2003amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R2145, December 9, 2003
Commission Regulation (EC) No 324/2004of 25 February 2004amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 304R0324, February 26, 2004
Commission Regulation (EC) No 546/2004of 24 March 2004amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 304R0546, March 25, 2004
Commission Regulation (EC) No 1101/2004of 10 June 2004amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Union L 211 of 12 June 2004), 304R1101304R1101R(01), June 12, 2004
Commission Regulation (EC) No 1646/2004of 20 September 2004amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance)Corrigendum to Commission Regulation (EC) No 1646/2004 of 20 September 2004 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Union L 296 of 21 September 2004), 304R1646304R1646R(02), September 21, 2004
Commission Regulation (EC) No 1851/2004of 25 October 2004amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits for veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 304R1851, October 26, 2004
Commission Regulation (EC) No 1875/2004of 28 October 2004amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate(Text with EEA relevance), 304R1875, October 29, 2004
Commission Regulation (EC) No 2232/2004of 23 December 2004amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazuril(Text with EEA relevance), 304R2232, December 24, 2004
Commission Regulation (EC) No 75/2005of 18 January 2005amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards moxidectin, linear alkyl benzene sulphonic acids with alkyl chain lengths ranging from C9 to C13, containing less than 2,5 % of chains longer than C13 and Acetylisovaleryltylosin(Text with EEA relevance), 305R0075, January 19, 2005

Corrected by

Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1442R(02), September 20, 1995
Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1442R(03), December 5, 1996
Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Com munity procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1442R(04), March 18, 1997
Corrigendum to Commission Regulation (EC) No 1568/98 of 17 July 1998 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 398R1568R(01), October 8, 1998
Corrigendum to Council Regulation (EC) No 1308/1999 of 15 June 1999 amending Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 399R1308R(01), January 13, 2000
Corrigendum to Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 301R0807R(01), May 16, 2001
Corrigendum to Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 301R1815R(01), October 9, 2001
Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 302R1181R(01), September 19, 2002
Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 302R1181R(02), February 19, 2003
Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 302R1181R(03), March 6, 2003
Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 304R1101R(01), November 13, 2004
Corrigendum to Commission Regulation (EC) No 1646/2004 of 20 September 2004 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 304R1646R(02), December 22, 2004

Council Regulation (EEC) No 2377/90of 26 June 1990laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin THE COUNCIL OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Economic Community, and in particular Article 43 thereof,Having regard to the proposal from the CommissionOJ No C 61, 10. 3. 1989. p. 5.,Having regard to the opinion of the European ParliamentOJ No C 96, 17. 4. 1990, p. 273.,Having regard to the opinion of the Economic and Social CommitteeOJ No C 201, 17. 8. 1989, p. 1.,Whereas the use of veterinary medicinal products in food-producing animals may result in the presence of residues of foodstuffs obtained from treated animals;Whereas as a result of scientific and technical progress it is possible to detect the presence of residues of veterinary medicines in foodstuffs at ever lower levels; whereas it is therefore necessary to establish maximum residue limits for pharmacologically active substances which are used in veterinary medicinal products in respect of all the various foodstuffs of animal origin, including meat, fish, milk, eggs and honey;Whereas in order to protect public health, maximum residue limits must be established in accordance with generally recognized principles of safety assessment, taking into account any other scientific assessment of the safety of the substances concerned which may have been undertaken by international organizations, in particular the Codex Alimentarius or, where such substances are used for other purposes, by other scientific committees established within the Community;Whereas the use of veterinary medicinal products plays an important part in agricultural production; whereas the establishment of maximum residue levels will facilitate the marketing of foodstuffs of animal origin;Whereas the establishment of different maximum residue levels by Member States may hinder the free movement of foodstuffs and of veterinary medicinal products themselves;Whereas it is therefore necessary to lay down a procedure for the establishment of maximum residue levels of veterinary medicinal products by the Community, following a single scientific assessment of the highest possible quality;Whereas the need for the establishment of maximum residue levels throughout the Community is recognized in the Community rules relating to trade in foodstuffs of animal origin;Whereas provisions must be adopted with a view to the systematic establishment of maximum residue levels for new substances capable of pharmacological action intended for administration to food-producing animals;Whereas arrangements must also be made for the establishment of maximum residue levels for substances which are currently used in veterinary medicines administered to food-producing animals; whereas, however, in view of the complexity of this matter and the large number of substances involved, long transitional arrangements are required;Whereas, after scientific assessment by the Committee for Veterinary Medicinal Products, maximum residue levels must be adopted by a rapid procedure which ensures close cooperation between the Commission and the Member States through the Committee set up under Council Directive 81/852/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal productsOJ No L 317, 6. 11. 1981, p. 16., as last amended by Directive 87/20/EECOJ No L 15, 17. 1. 1987, p. 34.; whereas an urgent procedure is also required to ensure the swift review of any tolerance which might prove insufficient to protect public health;Whereas medicinally induced immunological responses are usually indistinguishable from those which arise naturally, and do not affect consumers of food of animal origin;Whereas the information necessary to assess the safety of residues should be presented in accordance with the principles laid down by Directive 81/852/EEC,HAS ADOPTED THIS REGULATION:

Article 11.For the purposes of this Regulation, the following definitions shall apply:(a)"residues of veterinary medicinal products": means all pharmacologically active substances, whether active principles, excipients or degradation products, and their metabolites which remain in foodstuffs obtained from animals to which the veterinary medicinal product in question has been administered;(b)"maximum residue limit": means the maximum concentration of residue resulting from the use of a veterinary medicinal product (expressed in mg/kg or μg/kg on a fresh weight basis) which may be accepted by the Community to be legally permitted or recognized as acceptable in or on a food.It is based on the type and amount of residue considered to be without any toxicological hazard for human health as expressed by the acceptable daily intake (ADI), or on the basis of a temporary ADI that utilizes an additional safety factor. It also takes into account other relevant public health risks as well as food technology aspects.When establishing a maximum residue limit (MRL), consideration is also given to residues that occur in food of plant origin and/or come from the environment. Furthermore, the MRL may be reduced to be consistent with good practices in the use of veterinary drugs and to the extent that practical analytical methods are available.2.This Regulation shall not apply to active principles of biological origin intended to produce active or passive immunity or to diagnose a state of immunity used in immunological veterinary medicinal products.

Article 2The list of pharmacologically active substances used in veterinary medicinal products in respect of which maximum residue limits have been established shall be contained in Annex I, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex I shall be adopted in accordance with the same procedure.

Article 3Where, following an evaluation of a pharmacologically active substance used in veterinary medicinal products, it appears that it is not necessary for the protection of public health to establish a maximum residue limit, that substance shall be included in a list in Annex II, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex II shall be adopted in accordance with the same procedure.

Article 4A provisional maximum residue limit may be established for a pharmacologically active substance used in veterinary medicinal products on the date of entry into force of this Regulation, provided that there are no grounds for supposing that residues of the substance concerned at the level proposed present a hazard for the health of the consumer. A provisional maximum residue limit shall apply for a defined period of time, which shall not exceed five years. That period may be extended once only in exceptional cases for a period not in excess of two years if that proves expedient for the completion of scientific studies in progress.In exceptional circumstances, a provisional maximum residue limit may also be established for a pharmacologically active substance not previously used in veterinary medicinal products on the date of entry into force of this Regulation provided that there are no grounds for supposing that residues of the substance concerned at the limit proposed present a hazard for the health of the consumer.The list of pharmacologically active substances used in veterinary medicinal products in respect of which provisional maximum residue limits have been established shall be contained in Annex III, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex III shall be adopted in accordance with the same procedure.

Article 5Where it appears that a maximum residue limit cannot be established in respect of a pharmacologically active substance used in veterinary medicinal products because residues of the substances concerned, at whatever limit, in foodstuffs of animal origin constitute a hazard to the health of the consumer, that substance shall be included in a list in Annex IV, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex IV shall be adopted in accordance with the same procedure.The administration of the substances listed in Annex IV to food-producing animals shall be prohibited throughout the Community.

Article 61.In order to obtain the inclusion in Annexes I, II or III of a pharmacologically active substance which is intended for use in veterinary medicinal products for administration to food-producing animals, an application to establish a maximum residue limit shall be submitted to the European Agency for the Evaluation of Medicinal Products set up by Council Regulation (EEC) No 2309/93OJ L 214, 24.8.1993, p. 1, hereinafter referred to as "the Agency".This application shall contain the information and particulars referred to in Annex V of this Regulation and shall conform with the principles laid down in Directive 81/852/EEC.2.The application shall also be accompanied by the fee payable to the Agency.

Article 71.The Committee for Veterinary Medicinal Products referred to in Article 27 of Regulation (EC) No 2309/93 (hereinafter "the Committee") shall be responsible for formulating the Agency's opinion on the classification of substances referred to in Annexes I, II, III or IV to this Regulation.2.Articles 52 and 53 of Regulation (EEC) No 2309/93 shall be applicable for the purposes of this Regulation.3.The Agency shall ensure that the Committee's opinion is delivered within a period of 120 days following the reception of a valid application.If the information submitted by the applicant is not sufficient to enable such an opinion to be prepared, the Committee may ask the applicant to supply additional information within a specific time limit. The deadline for the opinion shall then be deferred until the additional information has been received.4.The Agency shall forward the opinion to the applicant. Within 15 days of receipt of the opinion, the applicant may provide written notice to the Agency that he wishes to appeal. In that case he shall forward the detailed grounds for his appeal to the Agency within 60 days of receipt of the opinion. Within 60 days of the receipt of the grounds for appeal, the Committee shall consider whether its opinion should be revised and the reasons for the conclusion reached on the appeal shall be annexed to the report referred to in paragraph 5.5.The Agency shall forward the definitive opinion of the Committee within 30 days of its adoption both to the Commission and to the applicant. The opinion shall be accompanied by a report describing the safety evaluation of the substance by the Committee, which shall give the grounds for its conclusions.6.The Commission shall prepare draft measures taking account of Community legislation and shall start the procedure provided for in Article 8. The Committee referred to in Article 8 shall adapt its rules of procedure in order to take account of the tasks conferred on it by this Regulation.

Article 81.The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products.2.Where reference is made to this Article, Articles 5 and 7 of Decision 1999/468/ECOJ L 184, 17.7.1999, p. 23. shall apply.The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months.3.The Standing Committee shall adopt its Rules of Procedure.

Article 91.Where a Member State, as a result of new information or a reassessment of existing information, considers that the urgent amendment of a provision contained in Annexes I to IV is necessary in order to protect human or animal health, and therefore requires swift action to be taken, that Member State may temporarily suspend the operation of the provision concerned in its own territory. In that case, it shall immediately notify the other Member States and the Commission of the measures, attaching a statement of the reasons therefor.2.The Commission shall as soon as possible examine the grounds given by the Member State concerned and, after consulting the Committee for Veterinary Medicinal Products, it shall then deliver its opinion forthwith and take appropriate measures; the person responsible for marketing may be requested to provide the Committee with oral or written explanations. The Commission shall immediately notify the Council and the Member States of any measures taken. Any Member State may refer the Commission's measures to the Council within 15 days of such notification. The Council, acting by a qualified majority, may take a different decision within 30 days of the date on which the matter was referred to it.3.If the Commission considers that it is necessary to amend the provision of Annex I to IV concerned in order to resolve the difficulties referred to in paragraph 1 and to ensure the protection of human health, it shall initiate the procedure laid down in Article 10 with a view to adopting those amendments; the Member State which has taken measures under paragraph 1 may maintain them until the Council or the Commission has taken a decision in accordance with the abovementioned procedure.

Article 101.The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products.2.Where reference is made to this Article, Articles 5 and 7 of Decision 1999/468/EC shall apply.The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at 15 days.

Article 11Any changes which are necessary to adapt Annex V to take account of scientific and technical progress shall be adopted in accordance with the procedure laid down in Article 2c of Directive 81/852/EEC.

Article 12As soon as possible after the amendment of Annexes I, II, III or IV, the Commission shall publish a summary of the assessment of the safety of the substances concerned that have been examined by the Committee for Veterinary Medicinal Products. The confidential nature of any proprietary data shall be respected. The Agency shall provide the competent authorities and the Commission with appropriate methods for identifying pharmacologically active substances for which the MRL's have been determined in Annexes I and III.

Article 13Member States may not prohibit or impede the putting into circulation within their territories of foodstuffs of animal origin originating in other Member States on the grounds that they contain residues of veterinary medicinal products if the quantity of residue does not exceed the maximum residue limit provided for in Annex I or III, or if the substance concerned is listed in Annex II.

Article 14With effect from 1 January 1997, the administration to food-producing animals of veterinary medicinal products containing pharmacologically active substances which are not mentioned in Annexes I, II or III shall be prohibited within the Community, except in the case of clinical trials accepted by the competent authorities following notification or authorization in accordance with the legislation in force and which do not cause foodstuffs obtained from livestock participating in such trials to contain residues which constitute a hazard to human health.However, the date referred to in the previous subparagraph shall be deferred for substances the use of which was authorized on the date of entry into force of this Regulation and in respect of which documented applications for the establishment of maximum residue limits have been lodged with the Commission or with the European Agency for the Evaluation of Medicinal Products before 1 January 1996:until 1 January 1998 in the case of pyrazolinones (including pyrazolidinediones and phenylbutazones), nitroimidazoles and arsalinic acid, anduntil 1 January 2000 in the case of other substances.The Agency shall publish a list of these substances before 7 June 1997.

Article 15This Regulation shall in no way prejudice the application of Community legislation prohibiting the use in livestock farming of certain substances having a hormonal action.Nothing in this Regulation shall prejudice the measures taken by Member States to prevent the unauthorized use of veterinary medicinal products.

Article 16This Regulation shall enter into force on 1 January 1992.

This Regulation shall be binding in its entirety and directly applicable in all Member States.ANNEX ILIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED1.Anti-infectious agents1.1.Chemotheurapeutics1.1.1.Sulfonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
All substances belonging to the sulfonamide group	Parent drug	All food-producing species	100 μg/kg	Muscle	The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg
			100 μg/kg	Fat
			100 μg/kg	Liver
			100 μg/kg	Kidney
		Bovine, ovine, caprine	100 μg/kg	Milk

1.1.2.Diamino pyrimidine derivatives

For porcine and poultry species this MRL relates to "skin and fat in natural proportions".For fin fish this MRL relates to "muscle and skin in natural proportions".

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Baquiloprim	Baquiloprim	Bovine	10 μg/kg	Fat
			300 μg/kg	Liver
			150 μg/kg	Kidney
			30 μg/kg	Milk
		Porcine	40 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
Trimethoprim	Trimethoprim	All food producing species except equidae	50 μg/kg	Fat	Not for use in animals from which eggs are produced for human consumption
			50 μg/kg	Muscle
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk
		Equidae	100 μg/kg	Muscle
			100 μg/kg	Fat
			100 μg/kg	Liver
			100 μg/kg	Kidney

1.2.Antibiotics1.2.1.Penicillins

For intramammary use only.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Amoxicyllin	Amoxicyllin	All food-producing species	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			4 μg/kg	Milk
Ampicillin	Ampicillin	All food-producing species	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			4 μg/kg	Milk
Benzylpenicillin	Benzylpenicillin	All food-producing species	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			4 μg/kg	Milk
Cloxacillin	Cloxacillin	All food-producing species	300 μg/kg	Muscle
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney
			30 μg/kg	Milk
Dicloxacillin	Dicloxacillin	All food-producing species	300 μg/kg	Muscle
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney
			30 μg/kg	Milk
Nafcillin	Nafcillin	All ruminants	300 µg/kg	Muscle
			300 µg/kg	Fat
			300 µg/kg	Liver
			300 µg/kg	Kidney
			30 µg/kg	Milk
Oxacillin	Oxacillin	All food-producing species	300 μg/kg	Muscle
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney
			30 μg/kg	Milk
Penethamate	Benzylpenicillin	Bovine	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			4 μg/kg	Milk
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
Phenoxymethylpenicillin	Phenoxymethylpenicillin	Porcine	25 μg/kg	Muscle
			25 μg/kg	Liver
			25 μg/kg	Kidney

1.2.2.Cephalosporins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cefacetrile	Cefacetrile	Bovine	125 μg/kg	Milk	For intramammary use only
Cefalexin	Cefalexin	Bovine	200 μg/kg	Muscle
			200 μg/kg	Fat
			200 μg/kg	Liver
			1000 μg/kg	Kidney
			100 μg/kg	Milk
Cefalonium	Cefalonium	Bovine	20 μg/kg	Milk
Cefapirin	Sum of cephapirin and desacetylcephapirin	Bovine	50 μg/kg	Muscle
			50 μg/kg	Fat
			100 μg/kg	Kidney
			60 μg/kg	Milk
Cefazolin	Cefazolin	Bovine, ovine, caprine	50 μg/kg	Milk
Cefoperazone	Cefoperazone	Bovine	50 μg/kg	Milk
Cefquinome	Cefquinome	Bovine	50 μg/kg	Muscle
			50 μg/kg	Fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
			20 μg/kg	Milk
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
		Equidae	50 μg/kg	Muscle
			50 μg/kg	Fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
Ceftiofur	Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur	Bovine	1000 μg/kg	Muscle
			2000 μg/kg	Fat
			2000 μg/kg	Liver
			6000 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine	1000 μg/kg	Muscle
			2000 μg/kg	Fat
			2000 μg/kg	Liver
			6000 μg/kg	Kidney

1.2.3.Quinolones

For fin fish this MRL relates to "muscle and skin in natural proportions".For porcine species this MRL relates to "skin and fat in natural proportions".

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Danofloxacin	Danofloxacin	All food producing species except bovine, ovine, caprine, porcine and poultry	100 μg/kg	Muscle
			50 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney
		Bovine, ovine, caprine	200 μg/kg	Muscle
			100 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney
			30 μg/kg	Milk
		Poultry	200 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			100 μg/kg	Skin and fat
			400 μg/kg	Liver
			400 μg/kg	Kidney
Difloxacin	Difloxacin	All food producing species except bovine, ovine, caprine and poultry	300 μg/kg	Muscle
			100 μg/kg	Fat
			800 μg/kg	Liver
			600 μg/kg	Kidney
		Bovine, ovine, caprine	400 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			100 μg/kg	Fat
			1400 μg/kg	Liver
			800 μg/kg	Kidney
		Porcine	400 μg/kg	Muscle
			100 μg/kg	Skin and fat
			800 μg/kg	Liver
			800 μg/kg	Kidney
		Poultry	300 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			400 μg/kg	Skin and fat
			1900 μg/kg	Liver
			600 μg/kg	Kidney
Enrofloxacin	Sum of enrofloxacin and ciprofloxacin	All food producing species except bovine, ovine, caprine, porcine, rabbits and poultry	100 μg/kg	Muscle
			100 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney
		Bovine, ovine, caprine	100 μg/kg	Muscle
			100 μg/kg	Fat
			300 μg/kg	Liver
			200 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine, rabbits	100 μg/kg	Muscle
			100 μg/kg	Fat
			200 μg/kg	Liver
			300 μg/kg	Kidney
		Poultry	100 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			100 μg/kg	Skin and fat
			200 μg/kg	Liver
			300 μg/kg	Kidney
Flumequine	Flumequine	All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish	200 μg/kg	Muscle
			250 μg/kg	Fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
		Bovine, porcine, ovine, caprine	200 μg/kg	Muscle
			300 μg/kg	Fat
			500 μg/kg	Liver
			1500 μg/kg	Kidney
			50 μg/kg	Milk
		Poultry	400 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			250 μg/kg	Skin and fat
			800 μg/kg	Liver
			1000 μg/kg	Kidney
		Fin fish	600 μg/kg	Muscle and skin in natural proportion
Marbofloxacin	Marbofloxacin	Bovine	150 μg/kg	Muscle
			50 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
			75 μg/kg	Milk
		Porcine	150 μg/kg	Muscle
			50 μg/kg	Skin and fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
Oxolinic acid	Oxolinic acid	Porcine	100 μg/kg	Muscle
			50 μg/kg	Skin and fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
		Chicken	100 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			50 μg/kg	Skin and fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
		Fin fish	100 μg/kg	Muscle and skin in natural proportions
Sarafloxacin	Sarafloxacin	Chicken	10 μg/kg	Skin and fat
			100 μg/kg	Liver
		Salmonidae	30 μg/kg	Muscle and skin in natural proportions

1.2.4.Macrolides

For fin fish this MRL relates to a "muscle and skin in natural proportions".For procine species this MRL relates to "skin and fat in natural proportions".For porcine and poultry species this MRL relates to "skin and fat in natural proportions".Not for use in animals from which milk is produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Acetylisovaleryltylosin	Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin	Porcine	50 μg/kg	Muscle
			50 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
Erythromycin	Erythromicyin A	All food producing species	200 μg/kg	Muscle
			200 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney
			40 μg/kg	Milk
			150 μg/kg	Eggs
Spiramycin	Sum of spiramycin and neospiramycin	Bovine	200 μg/kg	Muscle
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney
			200 μg/kg	Milk
		Chicken	200 μg/kg	Muscle
			300 μg/kg	Skin and fat
			400 μg/kg	Liver
	Spiramycin 1	Porcine	250 μg/kg	Muscle
			2000 μg/kg	Liver
			1000 μg/kg	Kidney
Tilmicosin	Tilmicosin	All food producing species except poultry	50 μg/kg	Muscle
			50 μg/kg	Fat
			1000 μg/kg	Liver
			1000 μg/kg	Kidney
			50 μg/kg	Milk
		Poultry	75 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			75 μg/kg	Sin and fat
			1000 μg/kg	Liver
			250 μg/kg	Kidney
Tulathromycin	(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents	Bovine	100 μg/kg	Fat
			3000 μg/kg	Liver
			3000 μg/kg	Kidney
		Porcine	100 μg/kg	Skin + fat
			3000 μg/kg	Liver
			3000 μg/kg	Kidney
Tylosin	Tylosin A	All food producing species	100 μg/kg	Fat
			100 μg/kg	Muscle
			100 μg/kg	Liver
			100 μg/kg	Kidney
			50 μg/kg	Milk
			200 μg/kg	Eggs

1.2.5.Florfenicol and related compounds

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Florfenicol	Sum of florfenicol and its metabolites measured as florfenicol-amine	All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish	100 μg/kg	Muscle
			200 μg/kg	Fat
			2000 μg/kg	Liver
			300 μg/kg	Kidney
		Bovine, ovine, caprine	200 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			3000 μg/kg	Liver
			300 μg/kg	Kidney
		Porcine	300 μg/kg	Muscle
			500 μg/kg	Skin and fat
			2000 μg/kg	Liver
			500 μg/kg	Kidney
		Poultry	100 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			200 μg/kg	Skin and fat
			2500 μg/kg	Liver
			750 μg/kg	Kidney
		Fin fish	1000 μg/kg	Muscle and skin in natural proportions
Thiamphenicol	Thiamphenicol	Bovine	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk
		Chicken	50 μg/kg	Muscle
		Not for use in animals from which eggs are produced for human consumption	50 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney

1.2.6.Tetracyclines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Chlortetracycline	Sum of parent drug and its 4- epimer	All food-producing species	100 μg/kg	Muscle
			300 μg/kg	Liver
			600 μg/kg	Kidney
			100 μg/kg	Milk
			200 μg/kg	Eggs
Doxycycline	Doxycycline	Bovine	100 μg/kg	Muscle
		Not for use in animals from which milk is produced for human consumption	300 μg/kg	Liver
			600 μg/kg	Kidney
		Porcine	100 μg/kg	Muscle
			300 μg/kg	Skin and fat
			300 μg/kg	Liver
			600 μg/kg	Kidney
		Poultry	100 μg/kg	Muscle
		Not for use in animals from which eggs are produced for human consumption	300 μg/kg	Skin and fat
			300 μg/kg	Liver
			600 μg/kg	Kidney
Oxytetracycline	Sum of parent drug and its 4-epimer	All food-producing species	100 μg/kg	Muscle
			300 μg/kg	Liver
			600 μg/kg	Kidney
			100 μg/kg	Milk
			200 μg/kg	Eggs
Tetracycline	Sum of parent drug and its 4-epimer	All food-producing species	100 μg/kg	Muscle
			300 μg/kg	Liver
			600 μg/kg	Kidney
			100 μg/kg	Milk
			200 μg/kg	Eggs

1.2.7.Naphtalene-ringed ansamycin

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Rifaximin	Rifaximin	Bovine	60 μg/kg	Milk

1.2.8.Pleuromutilines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Tiamulin	Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin	Porcine	100 μg/kg	Muscle
		Porcine	500 μg/kg	Liver
		Chicken	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			1000 μg/kg	Liver
		Rabbits	100 μg/kg	Muscle
		Rabbits	500 μg/kg	Liver
		Turkey	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			300 μg/kg	Liver
	Tiamulin		1000 μg/kg	Eggs
Valnemulin	Valnemulin	Porcine	50 μg/kg	Muscle
			500 μg/kg	Liver
			100 μg/kg	Kidney

1.2.9.Lincosamides

For porcine and poultry species this MRL relates to "skin and fat in natural proportions".For fin fish this MRL relates to "muscle and skin in natural proportions".

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Lincomycin	Lincomicyn	All food producing species	50 μg/kg	Fat
			100 μg/kg	Muscle
			500 μg/kg	Liver
			1500 μg/kg	Kidney
			150 μg/kg	Milk
			50 μg/kg	Eggs
Pirlimycin	Pirlimycin	Bovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			1000 μg/kg	Liver
			400 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			50 μg/kg	Skin and fat
			500 μg/kg	Liver
			1500 μg/kg	Kidney
		Chicken	100 μg/kg	Muscle
			50 μg/kg	Skin and fat
			500 μg/kg	Liver
			1500 μg/kg	Kidney
			50 μg/kg	Eggs

1.2.10.Aminoglycosides

For porcine and poultry species this MRL relates to "skin and fat in natural proportions".For fin fish this MRL relates to "muscle and skin in natural proportions".Not for use in animals from which eggs are produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Apramycin	Apramycin	Bovine	1000 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			1000 μg/kg	Fat
			10000 μg/kg	Liver
			20000 μg/kg	Kidney
Dihydrostreptomycin	Dihydrostreptomycin	Bovine, ovine	500 μg/kg	Muscle
			500 μg/kg	Fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	500 μg/kg	Muscle
			500 μg/kg	Skin and fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
Gentamicin	Sum of gentamicin C1, gentamicin C1a, gentamicin C2 and gentamicin C2a	Bovine	50 μg/kg	Muscle
			50 μg/kg	Fat
			200 μg/kg	Liver
			750 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Skin and fat
			200 μg/kg	Liver
			750 μg/kg	Kidney
Kanamycin	Kanamycin A	All food producing species except fish	100 μg/kg	Muscle
			100 μg/kg	Fat
			600 μg/kg	Liver
			2500 μg/kg	Kidney
			150 μg/kg	Milk
Neomycin (including framycetin)	Neomycin B	All food producing species	500 μg/kg	Fat
			500 μg/kg	Muscle
			500 μg/kg	Liver
			5000 μg/kg	Kidney
			1500 μg/kg	Milk
			500 μg/kg	Eggs
Paromomycin	Paromomycin	All food producing species	500 μg/kg	Muscle	Not for use in animals from which milk or eggs are produced for human consumption
			1500 μg/kg	Liver
			1500 μg/kg	Kidney
Spectinomycin	Spectinomycin	All food producing species except ovine	500 μg/kg	Fat	Not for use in animals from which eggs are produced for human consumption
			300 μg/kg	Muscle
			1000 μg/kg	Liver
			5000 μg/kg	Kidney
			200 μg/kg	Milk
		Ovine	300 μg/kg	Muscle
			500 μg/kg	Fat
			2000 μg/kg	Liver
			5000 μg/kg	Kidney
			200 μg/kg	Milk
Streptomycin	Streptomycin	Bovine, ovine	500 μg/kg	Muscle
			500 μg/kg	Fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	500 μg/kg	Muscle
			500 μg/kg	Skin and fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney

1.2.11.Other antibiotics

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Novobiocin	Novobiocin	Bovine	50 μg/kg	Milk

1.2.12.Polypeptides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Bacitracin	Sum of bacitracin A, bacitracin B, and bacitracin C	Bovine	100 μg/kg	Milk
		Rabbits	150 μg/kg	Muscle
			150 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney

1.2.13.Beta-lactamase inhibitors

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Clavulanic acid	Clavulanic acid	Bovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			200 μg/kg	Liver
			400 μg/kg	Kidney

1.2.14.Polymyxins

For porcine and poultry species this MRL relates to "skin and fat in natural proportions".For fin fish this MRL relates to "muscle and skin in natural proportions".

Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues
Colistin	Colistin	All food producing species	150 μg/kg	Fat
			150 μg/kg	Muscle
			150 μg/kg	Liver
			200 μg/kg	Kidney
			50 μg/kg	Milk
			300 μg/kg	Eggs

2.Antiparasitic agents2.1.Agents acting against endoparasites2.1.1.Salicylanilides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Closantel	Closantel	Bovine	1000 μg/kg	Muscle
			3000 μg/kg	Fat
			1000 μg/kg	Liver
			3000 μg/kg	Kidney
		Ovine	1500 μg/kg	Muscle
			2000 μg/kg	Fat
			1500 μg/kg	Liver
			5000 μg/kg	Kidney
Rafoxanide	Rafoxanide	Bovine	30 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			30 μg/kg	Fat
			10 μg/kg	Liver
			40 μg/kg	Kidney
		Ovine	100 μg/kg	Muscle
			250 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney

2.1.2.Tatra-hydro-imidazoles (imidazolthiazoles)

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Levamisole	Levamisole	Bovine, ovine, porcine, poultry	10 μg/kg	Muscle
			10 μg/kg	Fat
			100 μg/kg	Liver
			10 μg/kg	Kidney

2.1.3.Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Albendazole	Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole	All ruminants	100 μg/kg	Muscle
			100 μg/kg	Fat
			1000 μg/kg	Liver
			500 μg/kg	Kidney
			100 μg/kg	Milk
Albendazole oxide	Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole	Bovine, ovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			1000 μg/kg	Liver
			500 μg/kg	Kidney
			100 μg/kg	Milk
Febantel	Sum of extractable residues which may be oxidised to oxfendazole sulphone	All ruminants	50 μg/kg	Muscle
			50 μg/kg	Fat
			500 μg/kg	Liver
			50 μg/kg	Kidney
			10 μg/kg	Milk
Fenbendazole	Sum of extractable residues which may be oxidised to oxfendazole sulphone	All ruminants	50 μg/kg	Muscle
			50 μg/kg	Fat
			500 μg/kg	Liver
			50 μg/kg	Kidney
			10 μg/kg	Milk
Flubendazole	Sum of flubendazole and (2-amino 1H-benzimidazol-5-yl) (4fluorophenyl) methanone	Porcine, chicken, game birds	50 μg/kg	Muscle
			50 μg/kg	Skin and fat
			400 μg/kg	Liver
			300 μg/kg	Kidney
		Turkey	50 μg/kg	Muscle
			50 μg/kg	Skin and fat
			400 μg/kg	Liver
			300 μg/kg	Kidney
	Flubendazole	Chicken	400 μg/kg	Eggs
Mebendazole	Sum of mebendazole methyl (5-(1-hydroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents	Ovine, caprine, equidae	60 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			60 μg/kg	Fat
			400 μg/kg	Liver
			60 μg/kg	Kidney
Netobimin	Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole	Bovine, ovine	100 μg/kg	Muscle	For oral use only
			100 μg/kg	Fat
			1000 μg/kg	Liver
			500 μg/kg	Kidney
			100 μg/kg	Milk
Oxfendazole	Sum of extractable residues which may be oxidised to oxfendazole sulphone	All ruminants	50 μg/kg	Muscle
			50 μg/kg	Fat
			500 μg/kg	Liver
			50 μg/kg	Kidney
			10 μg/kg	Milk
Oxibendazole	Oxibendazole	Porcine	100 μg/kg	Muscle
			500 μg/kg	Skin and fat
			200 μg/kg	Liver
			100 μg/kg	Kidney
Thiabendazole	Sum of thiabendazole and 5-hydroxythiabendazole	Caprine	100 μg/kg	Muscle
			100 μg/kg	Fat
			100 μg/kg	Liver
			100 μg/kg	Kidney
			100 μg/kg	Milk
Triclabendazole	Sum of extractable residues that may be oxidised to ketotriclabendazole	Bovine, ovine	100 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			100 μg/kg	Liver
			100 μg/kg	Kidney

2.1.4.Phenol derivatives including salicylanides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Nitroxinil	Nitroxinil	Bovine, ovine	400 μg/kg	Muscle
			200 μg/kg	Fat
			20 μg/kg	Liver
			400 μg/kg	Kidney
Oxyclozanide	Oxyclozanide	All ruminants	20 μg/kg	Muscle
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney
			10 μg/kg	Milk

2.1.5.Benzenesulphonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Clorsulon	Clorsulon	Bovine	35 μg/kg	Muscle
			100 μg/kg	Liver
			200 μg/kg	Kidney

2.1.6.Piperazine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Piperazine	Piperazine	Porcine	400 μg/kg	Muscle
			800 μg/kg	Skind and fat
			2000 μg/kg	Liver
			1000 μg/kg	Kidney
		Chicken	2000 μg/kg	Eggs

2.1.7.Tetrahydropyrimides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Morantel	Sum of residues which may be hydrolysed to N-methyl-1,3- propanediamine and expressed as morantel equivalents	Bovine, ovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			800 μg/kg	Liver
			200 μg/kg	Kidney
			50 μg/kg	Milk

2.2.Agents acting against ectoparasites2.2.1.Organophosphates

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Coumafos	Coumafos	Bees	100 μg/kg	Honey
Diazinon	Diazinon	Bovine, ovine, caprine	20 μg/kg	Milk
		Bovine, porcine, ovine, caprine	20 μg/kg	Muscle
			700 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
Phoxim	Phoxim	Ovine	50 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			400 μg/kg	Fat
			50 μg/kg	Kidney
		Porcine	20 μg/kg	Muscle
			700 μg/kg	Skin and fat
			20 μg/kg	Liver
			20 μg/kg	Kidney

2.2.2.Formamidines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Amitraz	Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz	Bovine	200 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney
			10 μg/kg	Milk
		Ovine	400 μg/kg	Fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
			10 μg/kg	Milk
		Porcine	400 μg/kg	Skin and fat
			200 μg/kg	Liver
			200 μg/kg	Kidney
		Bees (honey)	200 μg/kg	Honey
		Caprine	200 μg/kg	Fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
			10 μg/kg	Milk

2.2.3.Pyrethroids

Further provisions in Commission Directive 98/82/EC are to be observed (OJ L 290, 29.10.1998, p. 25).

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyhalothrin	Cyhalothrin (sum of isomers)	Bovine	500 μg/kg	Fat	Further provisions in Council Directive 94/29/EC are to be observed
			50 μg/kg	Kidney
			50 μg/kg	Milk
Cyfluthrin	Cyfluthrin (sum of isomers)	Bovine	10 μg/kg	Muscle
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
Deltamethrin	Deltamethrin	All ruminants	10 μg/kg	Muscle
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
		Fin fish	10 μg/kg	Muscle and skin in natural proportions
Flumethrin	Flumethrin (sum of trans-Z isomers)	Bovine	10 μg/kg	Muscle
			150 μg/kg	Fat
			20 μg/kg	Liver
			10 μg/kg	Kidney
			30 μg/kg	Milk
		Ovine	10 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			150 μg/kg	Fat
			20 μg/kg	Liver
			10 μg/kg	Kidney
Permethrin	Permethrin (sum of isomers)	Bovine	50 μg/kg	Muscle
			500 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk
Cypermethrin	Cypermethrin (sum of isomers)	Salmonidae	50 μg/kg	Muscle and skin in natural proportions
		All ruminants	20 μg/kg	Muscle
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk
Alphacypermethrin	Cypermethrin (sum of isomers)	Bovine, ovine	20 μg/kg	Muscle
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk

2.2.4.Acyl urea derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Diflubenzuron	Diflubenzuron	Salmonidae	1000 μg/kg	Muscle and skin in natural proportions
Teflubenzuron	Teflubenzuron	Salmonidae	500 μg/kg	Muscle and skin in natural proportions

2.2.5.Pyrimidines derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Dicyclanil	Sum of dicyclanil and 2, 4, 6-triamino-pyrimidine-5-carbonitrile	Ovine	200 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			150 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney

2.2.6.Triazine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyromazine	Cyromazine	Ovine	300 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney

2.3.Agents acting against endo- and ectoparasites2.3.1.Avermectins

Phramacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Abamectin	Avermectin B1a	Bovine	10 μg/kg	Fat
			20 μg/kg	Liver
		Ovine	20 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			50 μg/kg	Fat
			25 μg/kg	Liver
			20 μg/kg	Kidney
Doramectin	Doramectin	Bovine	10 μg/kg	Muscle	Not for use in bovine from which milk is produced for human consumption
			150 μg/kg	Fat
			100 μg/kg	Liver
			30 μg/kg	Kidney
		Porcine, ovine	20 μg/kg	Muscle	Not for use in ovine from which milk is produced for human consumption
			100 μg/kg	Fat
			50 μg/kg	Liver
			30 μg/kg	Kidney
		Deer, including reindeer	20 μg/kg	Muscle
			100 μg/kg	Fat
			50 μg/kg	Liver
			30 μg/kg	Kidney
Emamectin	Emamectin B1a	Fin fish	100 μg/kg	Muscle and skin in natural proportions
Eprinomectin	Eprinomectin B1a	Bovine	50 μg/kg	Muscle
			250 μg/kg	Fat
			1500 μg/kg	Liver
			300 μg/kg	Kidney
			20 μg/kg	Milk
Ivermectin	22, 23-Dihydro-avermectin B1a	Bovine	40 μg/kg	Fat
			100 μg/kg	Liver
		Porcine, ovine, equidae	20 μg/kg	Fat
			15 μg/kg	Liver
		Deer, including reindeer	20 μg/kg	Muscle
			100 μg/kg	Fat
			50 μg/kg	Liver
			20 μg/kg	Kidney
Moxidectin	Moxidectin	Bovine, ovine	50 μg/kg	Muscle
			500 μg/kg	Fat
			100 μg/kg	Liver
			50 μg/kg	Kidney
		Bovine	40 μg/kg	Milk
		Equidae	50 μg/kg	Muscle
			500 μg/kg	Fat
			100 μg/kg	Liver
			50 μg/kg	Kidney
		Ovine	40 μg/kg	Milk

2.4.Agents acting against protozoa2.4.1.Triazinetrione derivative

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Toltrazuril	Toltrazuril sulfone	Chicken	100 μg/kg	Muscle	Not for use in animals from which eggs are produced for human consumption
			200 μg/kg	Skin and fat
			600 μg/kg	Liver
			400 μg/kg	Kidney
		Turkey	100 μg/kg	Muscle
			200 μg/kg	Skin and fat
			600 μg/kg	Liver
			400 μg/kg	Kidney
		Porcine	100 μg/kg	Muscle
			150 μg/kg	Skin and fat
			500 μg/kg	Liver
			250 μg/kg	Kidney

2.4.2.Quinazolone derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Halofuginone	Halofuginone	Bovine	10 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			25 μg/kg	Fat
			30 μg/kg	Liver
			30 μg/kg	Kidney

2.4.3.Carbanilides

Not for use in ovine from which milk is produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Imidocarb	Imidocarb	Bovine	300 μg/kg	Muscle
			50 μg/kg	Fat
			2000 μg/kg	Liver
			1500 μg/kg	Kidney
			50 μg/kg	Milk
		Ovine	300 μg/kg	Muscle
			50 μg/kg	Fat
			2000 μg/kg	Liver
			1500 μg/kg	Kidney

3.Agents acting on the nervous system3.1.Agents acting on the central nervous system3.1.1.Butyrophenone tranquillisers

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Azaperone	Sum of azaperone and azaperol	Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			100 μg/kg	Liver
			100 μg/kg	Kidney

3.2.Agents acting on the autonomic nervous system3.2.1.Anti-adrenergics

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Carazolol	Carazolol	Porcine	5 μg/kg	Muscle
			5 μg/kg	Skin and fat
			25 μg/kg	Liver
			25 μg/kg	Kidney
		Bovine	5 μg/kg	Muscle
			5 μg/kg	Fat
			15 μg/kg	Liver
			15 μg/kg	Kidney
			1 μg/kg	Milk

3.2.2.β2 sympathomimetic agents

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Clenbuterol hydrochloride	Clenbuterol	Bovine	0,1 μg/kg	Muscle
			0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
			0,05 μg/kg	Milk
		Equidae	0,1 μg/kg	Muscle
			0,5 μg/kg	Liver
			0,5 μg/kg	Kidney

4.Anti-inflammatory agents4.1.Nonsteroidal anti-inflammatory agents4.1.1.Arylpropionic acid derivative

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Carprofen	Carprofen	BovineNot for use in animals from which milk is produced for human consumption	500 μg/kg	Muscle
			1000 μg/kg	Fat
			1000 μg/kg	Liver
			1000 μg/kg	Kidney
		Equidae	500 μg/kg	Muscle
			1000 μg/kg	Fat
			1000 μg/kg	Liver
			1000 μg/kg	Kidney
Vedaprofen	Vedaprofen	Equidae	50 μg/kg	Muscle
			20 μg/kg	Fat
			100 μg/kg	Liver
			1000 μg/kg	Kidney

4.1.2.Fenamate group derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Flunixin	Flunixin	Bovine	20 μg/kg	Muscle
			30 μg/kg	Fat
			300 μg/kg	Liver
			100 μg/kg	Kidney
	5-Hydroxyflunixin		40 μg/kg	Milk
	Flunixin	Porcine	50 μg/kg	Muscle
			10 μg/kg	Skin and fat
			200 μg/kg	Liver
			30 μg/kg	Kidney
		Equidae	10 μg/kg	Muscle
			20 μg/kg	Fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
Tolfenamic acid	Tolfenamic acid	Bovine	50 μg/kg	Muscle
			400 μg/kg	Liver
			100 μg/kg	Kidney
			50 μg/kg	Milk
		Porcine	50 μg/kg	Muscle
			400 μg/kg	Liver
			100 μg/kg	Kidney

4.1.3.Enolic acid derivates

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Meloxicam	Meloxicam	Equidae	20 μg/kg	Muscle
			65 μg/kg	Liver
			65 μg/kg	Kidney

4.1.4.Oxican derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Meloxicam	Meloxicam	Bovine	20 μg/kg	Muscle
			65 μg/kg	Liver
			65 μg/kg	Kidney
			15 μg/kg	Milk
		Porcine	20 μg/kg	Muscle
			65 μg/kg	Liver
			65 μg/kg	Kidney

4.1.5.Pyrazolone derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Metamizole	4-Methylaminoantipyrin	Bovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			100 μg/kg	Liver
			100 μg/kg	Kidney
			50 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			100 μg/kg	Liver
			100 μg/kg	Kidney
		Equidae	100 μg/kg	Muscle
			100 μg/kg	Fat
			100 μg/kg	Liver
			100 μg/kg	Kidney

4.1.6.Phenyl acetic acid derivatives

Not for use in animals from which milk is produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Diclofenac	Diclofenac	Bovine	5 μg/kg	Muscle
			1 μg/kg	Fat
			5 μg/kg	Liver
			10 μg/kg	Kidney
		Porcine	5 μg/kg	Muscle
			1 μg/kg	Skin + fat
			5 μg/kg	Liver
			10 μg/kg	Kidney

5.Corticoides5.1.Glucocorticoides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Betamethasone	Betamethasone	Bovine	0,75 μg/kg	Muscle
			2,0 μg/kg	Liver
			0,75 μg/kg	Kidney
			0,3 μg/kg	Milk
		Porcine	0,75 μg/kg	Muscle
			2,0 μg/kg	Liver
			0,75 μg/kg	Kidney
Dexamethasone	Dexamethasone	Bovine	0,3 μg/kg	Milk
		Bovine, porcine, equidae	0,75 μg/kg	Muscle
			2 μg/kg	Liver
			0,75 μg/kg	Kidney
		Caprine	0,75 μg/kg	Muscle
			2 μg/kg	Liver
			0,75 μg/kg	Kidney
			0,3 μg/kg	Milk
Methylprednisolone	Methylprednisolone	Bovine	10 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			10 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
Prednisolone	Prednisolone	Bovine	4 μg/kg	Muscle
			4 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			6 μg/kg	Milk

6.Agents acting on the reproductive system6.1.Progestogens

Only for zootechnical use and in accordance with the provisions of Directive 96/22/EC.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Chlormadinone	Chlormadinone	Bovine	4 μg/kg	Fat	For zootechnical use only
			2 μg/kg	Liver
			2,5 μg/kg	Milk
Flugestone acetate	Flugetone acetate	Ovine	1 μg/kg	Milk	For intravaginal use for zootechnical purposes only
Flugestone acetate	Flugetone acetate	Caprine	1 μg/kg	Milk	For intra-vaginal use for zootechnical purposes only
Altrenogest	Altrenogest	Porcine	1 μg/kg	Skin and fat
		Porcine	0,4 μg/kg	Liver
		Equidae	1 μg/kg	Fat
		Equidae	0,9 μg/kg	Liver

ANNEX IILIST OF SUBSTANCES NOT SUBJECT TO MAXIMUM RESIDUE LIMITS1.Inorganic chemicals

Pharmacologically active substance(s)	Animal species	Other provisions
Aluminium distearate	All food-producing species
Aluminium hydroxide acetate	All food-producing species
Aluminium phosphate	All food-producing species
Aluminium salicylate, basic	Bovine	For oral use only; Not for use in animals from which milk is produced for human consumption
Aluminium tristearate	All food-producing species
Ammonium chloride	All food-producing species
Barium selenate	Bovine, ovine
Bismuth subcarbonate	All food-producing species	For oral use only
Bismuth subgallate	All food-producing species	For oral use only
Bismuth subnitrate	All food-producing species	For oral use only
Bismuth subsalicylate	All food-producing species	For oral use only
Boric acid and borates	All food-producing species
Bromide, potassium salt	All food producing species
Bromide, sodium salt	All mammalian food-producing species	For topical use only
Calcium acetateCalcium benzoateCalcium carbonateCalcium chlorideCalcium gluconateCalcium hydroxideCalcium hypophosphiteCalcium malateCalcium oxideCalcium phosphateCalcium polyphosphatesCalcium propionateCalcium silicateCalcium stearateCalcium sulphate	All food-producing species
Calcium glucoheptonate	All food-producing species
Calcium glucono glucoheptonate	All food-producing species
Calcium gluconolactate	All food-producing species
Calcium glutamate	All food-producing species
Calcium glycerophosphate	All food producing species
Cobalt carbonate	All food-producing species
Cobalt dichloride	All food-producing species
Cobalt gluconate	All food-producing species
Cobalt oxide	All food-producing species
Cobalt sulphate	All food-producing species
Cobalt trioxide	All food-producing species
Copper chloride	All food-producing species
Copper gluconate	All food-producing species
Copper heptanoate	All food-producing species
Copper methionate	All food-producing species
Copper oxide	All food-producing species
Copper sulphate	All food-producing species
Dicopper oxide	All food-producing species
Hydrochloric acid	All food-producing species	For use as excipient
Hydrogen peroxide	All food-producing species
Iodine and iodine inorganic compounds including:Sodium and potassium-iodideSodium and potassium-iodateIodophors including polyvinylpyrrolidone-iodine	All food-producing species
Iron dichloride	All food-producing species
Iron sulphate	All food-producing species
MagnesiumMagnesium sulphateMagnesium hydroxideMagnesium stearateMagnesium glutamateMagnesium orotateMagnesium aluminium silicateMagnesium oxideMagnesium carbonateMagnesium phosphateMagnesium glycerophosphateMagnesium aspartateMagnesium citrateMagnesium acetateMagnesium trisilicate	All food-producing species
Nickel gluconate	All food-producing species
Nickel sulphate	All food-producing species
Potassium DL-aspartate	All food-producing species
Potassium glucuronate	All food-producing species
Potassium glycerophosphate	All food-producing species
Potassium nitrate	All food-producing species
Potassium selenate	All food-producing species
Sodium chlorite	Bovine	For topical use only
Sodium dichloroisocyanurate	Bovine, ovine, caprine	For topical use only
Sodium glycerophosphate	All food producing species
Sodium hypophosphite	All food-producing species
Sodium propionate	All food producing species
Sodium selenate	All food-producing species
Sodium selenite	All food-producing species
Sulphur	All food producing species
Zinc acetateZinc chlorideZinc gluconateZinc oleateZinc stearate	All food-producing species

2.Organic compounds

Only for intravaginal therapeutic or zootechnical use and in accordance with the provisions of Directive 96/22/EC.For oral use only.For oral use; not for use in animals from which milk is produced for human consumption.For inhalation use only.For topical use only.

Pharmacologically active substance(s)	Animal species	Other provisions
17β-Oestradiol	All mammalian food-producing species	For therapeutic and zootechnical uses only
2-Aminoethanol	All food-producing species
2-Aminoethyl dihydrogenphosphate	All food-producing species
2-Pyrrolidone	All food-producing species	At parenteral doses up to 40 mg/kg bw
8-Hydroxyquinoline	All mammalian food-producing species	For topical use in newborn animals only
Acetyl cysteine	All food-producing species
Alfacalcidol	Bovine	For parturient cows only
Alfaprostol	RabbitsBovine, porcine, equidae
Bacitracin	Bovine	For intramammary use in lactating cows only and for all tissues except milk
Benzalkonium chloride	All food-producing species	For use as an excipient at concentrations up to 0,05 % only
Benzocaine	All food-producing species	For use as local anaesthetic only
Benzylalcohol	All food-producing species	For use as excipient
Betaine	All food-producing species
Bronopol	Salmonidae	For use only on farmed fertilised eggs
Brotizolam	Bovine	For therapeutic uses only
Buserelin	All food-producing species
Butorphanol tartrate	Equidae	For intravenous administration only
Butyl 4-hydroxybenzoate	All food-producing species
Butylscopolaminium bromide	All food-producing species
Caffeine	All food-producing species
Carbetocin	All mammalian food-producing species
Cefazolin	BovineOvine, caprine	For intramammary use, except if the udder may be used as food for human consumption
Cetostearyl alcohol	All food-producing species
Cetrimide	All food-producing species
Chlorhexidine	All food-producing species	For topical use only
Chlorocresol	All food-producing species
Clazuril	Pigeon
Cloprostenol	Bovine, porcine, equidae
Coco alkyl dimethyl betaines	All food-producing species	For use as excipient
Corticotropin	All food-producing species
D-Phe 6 -luteinising-hormone releasing hormone	All food-producing species
Dembrexine	Equidae
Denaverine hydrochloride	Bovine
Detomidine	Bovine, equidae	For therapeutic uses only
Diclazuril	All ruminantsPorcine
Diethyl phtalate	All food-producing species
Diethylene glycol monoethyl ether	Bovine, porcine
Dimanganese trioxide	All food-producing species	For oral use only
Dimethyl phtalate	All food-producing species
Dinoprost	All mammalian food-producing species
Dinoprost tromethamine	All mammalian food-producing species
Diprophylline	All food-producing species
Etamiphylline camsylate	All food-producing species
Ethanol	All food-producing species	For use as excipient
Ethyl lactate	All food-producing species
Etiproston tromethamine	Bovine, porcine
Fertirelin acetate	Bovine
Flumethrin	Bees (honey)
Folic acid	All food-producing species
Glycerol formal	All food-producing species
Gonadotrophin releasing hormone	All food-producing species
Heptaminol	All food-producing species
Hesperidin	Equidae
Hesperidin methyl chalcone	Equidae
Hexetidine	Equidae	For topical use only
Human chorion gonadotrophin	All food-producing species
Human menopausal urinary gonadotrophin	Bovine
Hydrocortisone	All food-producing species	For topical use only
Iodine organic compoundsIodoform	All food-producing species
Isobutane	All food-producing species
Isoflurane	Equidae	For use as anaesthetic only
Isoxsuprine	Bovine, equidae	For therapeutic use only in accordance with Council Directive 96/22/EEC (OJ L 125, 23.5.1996, p. 3)
Ketamine	All food-producing species
Ketanserin tartrate	Equidae
Ketoprofen	Bovine, porcine, equidae
L-tartaric acid and its mono- and di-basic salt of sodium, potassium and calcium	All food-producing species	For use as excipient
Lactic acid	All food-producing species
Lecirelin	Bovine, equidae, rabbits
Lobeline	All food-producing species
Luprostiol	All mammalian species
Malic acid	All food-producing species	For use as excipient
Manganese carbonate	All food-producing species	For oral use only
Manganese chloride	All food-producing species	For oral use only
Manganese gluconate	All food-producing species	For oral use only
Manganese glycerophosphate	All food-producing species	For oral use only
Manganese oxide	All food-producing species	For oral use only
Manganese pidolate	All food-producing species	For oral use only
Manganese ribonucleate	All food-producing species	For oral use only
Manganese sulphate	All food-producing species	For oral use only
Mecillinam	Bovine	For intrauterine use only
Medroxyprogesterone acetate	Ovine	For intravaginal use for zootechnical purposes only
Melatonin	Ovine, caprine
Menadione	All food-producing species
Menbutone	Bovine, ovine, caprine, porcine, equidae
Menthol	All food-producing species
Methyl nicotinate	Bovine, equidae	For topical use only
Mineral hydrocarbons, low to high viscosity including microcristalline waxes, approximately C10-C60; aliphatic, branched aliphatic and alicyclic compounds	All food-producing species	Excludes aromatic and unsaturated compounds
N-butane	All food-producing species
N-butanol	All food-producing species	For use as excipient
Natamycin	Bovine, equidae	For topical use only
Neostigmine	All food-producing species
Nicoboxil	Equidae	For topical use only
Nonivamide	Equidae	For topical use only
Oleyloleate	All food-producing species	For topical use only
Oxytocin	All mammalian food-producing species
Pancreatin	All mammalian food-producing species	For topical use only
Papain	All food-producing species
Papaverine	Bovine	Newborn calves only
Peracetic acid	All food-producing species
Phenol	All food-producing species
Phloroglucinol	All food-producing species
Phytomenadione	All food-producing species
Policresulen	All food-producing species	For topical use only
Polyethylene glycol 15 hydroxystearate	All food-producing species	For use as excipient
Polyethylene glycol 7 glyceryl cocoate	All food-producing species	For topical use only
Polyethylene glycol stearates with 8-40 oxyethylene units	All food-producing species	For use as excipient
Polysulphated glycosaminoglycan	Equidae
Praziquantel	OvineEquidae	For use in non-lactating sheep only
Pregnant mare serum gonadotrophin	All food-producing species
Prethcamide (crotethamide and cropropamide)	All mammalian food-producing species
Procaine	All food-producing species
Propane	All food-producing species
Propylene glycol	All food-producing species
Quatresin	All food-producing species	For use as preservative only at concentrations of up to 0,5 %
R-Cloprostenol	Bovine, porcine, equidae
Rifaximin	All mammalian food-producing speciesBovine	For topical use onlyFor intramammary use, except if the udder may be used as food for human consumption
Romifidine	Equidae	For therapeutic uses only
Sodium 2-methyl-2-phenoxy-propanoate	Bovine, porcine, caprine, equidae
Sodium benzyl 4-hydroxybenzoate	All food-producing species
Sodium butyl 4-hydroxybenzoate	All food-producing species
Sodium cetostearyl sulphate	All food-producing species	For topical use only
Somatosalm	Salmon
Tanninum	All food-producing species
Tau fluvalinate
Terpin hydrate	Bovine, porcine, ovine, caprine
Tetracaine	All food-producing species	For use as anaesthetic only
Theobromine	All food-producing species
Theophylline	All food-producing species
Thiomersal	All food-producing species	For use only as preservatives in multidose vaccines at a concentration not exceeding 0,02 %
Thymol	All food-producing species
Timerfonate	All food-producing species	For use only as preservatives in multidose vaccines at a concentration not exceeding 0,02 %
Trimethylphloroglucinol	All food-producing species
Vitamin D	All food-producing species
Wool alcohols	All food-producing species	For topical use only
1-Methyl-2-pyrrolidone	Equidae
Cefacetrile	Bovine	For intramammary use only and for all tissues except milk
Enilconazole	Bovine, equidae	For topical use only
Etamsylate	All food producing species
Strychnine	Bovine	For oral use only at dose to 0,1 mg/kg bw
Parconazole	Guinea fowl
Biotin	All food producing species
Bromhexine	BovineNot for use in animals from which milk is produced for human consumption
	Porcine
	PoultryNot for use in animals from which eggs are produced for human consumption
Mercaptamine hydrochloride	All mammalian food-producing species
Praziquantel	Ovine
Pyrantel embonate	Equidae
Vitamin B1	All food-producing species
Vitamin B12	All food-producing species
Vitamin B2	All food-producing species
Vitamin B3	All food-producing species
Vitamin B5	All food-producing species
Vitamin B6	All food-producing species
Vitamin E	All food-producing species
Tiaprost	Bovine, ovine, porcine, equidae
Apramycin	Porcine, rabbitsOvineNot for use in animals from which milk is produced for human consumptionChickenNot for use in animals from which eggs are produced for human consumption	For oral use only
Azamethiphos	Salmonidae
Doxapram	All mammalian food producing species
Piperonyl butoxide	Bovine, ovine, caprine, equidae	For topical use only
Sulfogaiacol	All food producing species
Vetrabutine hydrochloride	Porcine
Fenpipramide hydrochloride	Equidae	For intravenous use only
Hydrochlorothiazide	Bovine
Levomethadone	Equidae	For intravenous use only
Tricaine mesilate	Fin fish	For water borne use only
Trichlormethiazide	All mammalian food producing species	Not for use in animals from which milk is produced for human consumption
Vincamine	Bovine	For use in newborn animals only
Atropine	All food producing species
Cefoperazone	Bovine	For intramammary use in lactating cows only and for all tissues except milk
2-aminoethanol glucuronate	All food-producing species
Betaine glucuronate	All food-producing species
Bituminosulfonates, ammonium and sodium salts	All mammalian food-producing species	For topical use onlyNot for use in animals from which milk is produced for human consumption
Chlorphenamine	All mammalian food-producing species
Humic acids and their sodium salts	All food-producing species	For oral use only
Paracetamol	Porcine	For oral use only
Tosylchloramide sodium	Fin fish	For water-borne use only
	Bovine	For topical use only
1-methyl-2-pyrrolidone	All food-producing species
Ergometrine maleate	All mammalian food-producing species	For use in parturient animals only
Jecoris oleum	All food-producing species	For topical use only
Mepivacaine	Equidae	For intra-articular and epidural use as local anaesthetic only
Novobiocin	Bovine	For intrammary use only and for all tissues except milk
Piperazine dihydrochloride	Chicken	For all tissues except eggs
Polyoxyl castor oil with 30 to 40 oxyethylene units	All food-producing species	For use as excipient
Polyoxyl hydrogenated castor oil with 40 to 60 oxyethylene units	All food-producing species	For use as excipient
Xylazine hydrochloride	Bovine, equidae	Not for use in animals from which milk is produced for human consumptiom
Butafosfan	Bovine	For intravenous use only
Cefalonium	Bovine	For intramammary use and eye treatment only, and for all tissues except milk
Furosemide	Bovine, equidae	For intravenous administration only
Lidocaine	Equidae	For local-regional anaesthesia only
3,5-Diiodo-L-thyrosine	All mammalian food-producing species
Levothyroxine	All mammalian food-producing species
Aluminium salicylate, basic	All food producing species except fish For topical use only
Bismuth subnitrate	Bovine	For intramammary use only
Calcium aspartate	All food producing species
Methyl salicylate	All food producing species except fish	For topical use only
Salicylic acid	All food producing species except fish	For topical use only
Sodium salicylate	Bovine, porcine
Zinc aspartate	All food producing species
Toldimfos	All food producing species
Decoquinate	Bovine, ovine	For oral use only. Not for use in animals from which milk is produced for human consumption
Sodium boroformiate	All food producing species
Thiamylal	All mammalian food producing species	For intravenous administration only
Thiopental sodium	All food-producing species	For intravenous administration only
Acetylsalicylic acid	All food producing species except fish	Not for use in animals from which milk or eggs are produced for human consumption
Acetylsalicylic acid DL-lysine	All food producing species except fish	Not for use in animals from which milk or eggs are produced for human consumption
Carbasalate calcium	All food producing species except fish	Not for use in animals from which milk or eggs are produced for human consumption
Sodium acetylsalicylate	All food producing species except fish	Not for use in animals from which milk or eggs are produced for human consumption
Linear alkyl benzene sulphonic acids with alkyl chain lengths ranging from C9 to C13, containing less than 2,5 % of chains longer than C13	Bovine	For topical use only
	Ovine
Amprolium	Poultry	For oral use only
Tiludronic acid, disodium salt	Equidae	For intravenous use only
Sorbitan trioleate	All food-producing species
Vitamin A	All food producing species
Ammonium lauryl sulphate	All food-producing species
Bronopol	Fin fish
Calcium pantothenate	All food-producing species
Allantoin	All food producing species	For topical use only
Benzocaine	Salmonidae
Dexpanthenol	All food producing species
Azagly-nafarelin	Salmonidae	Not for use in fish from which eggs are produced for human consumption
Deslorelin acetate	Equidae
Hydroxyethylsalicylate	All food producing species except fish	For topical use only
Xylazine hydrochloride	Bovine, equidae
Omeprazole	Equidae	For oral use only
Trichlormethiazide	All mammalian food producing species
Progesterone	Bovine, ovine, caprine, Equidae (female)
Beclomethasone dipropionate	Equidae
Cloprostenol	Caprine
R-cloprostenol	Caprine
Sorbitan sesquioleate	All food producing species

3.Substances generally recognised as safe

Pharmacologically active substance(s)	Animal species	Other provisions
Absinthium extract	All food-producing species
Acetylmethionine	All food-producing species
Aluminium hydroxide	All food-producing species
Aluminium monostearate	All food-producing species
Ammonium sulfate	All food-producing species
Benzoyl benzoate	All food-producing species
Benzyl p-hydroxybenzoate	All food-producing species
Calcium borogluconate	All food-producing species
Calcium citrate	All food-producing species
Camphor	All food-producing species	External use only
Cardamon extract	All food-producing species
Diethyl sebacate	All food-producing species
Dimethicone	All food-producing species
Dimethyl acetamide	All food-producing species
Dimethyl sulphoxide	All food-producing species
Epinephrine	All food-producing species
Ethyl oleate	All food-producing species
Ethylenediaminetetraacetic acid and salts	All food-producing species
Eucalyptol	All food-producing species
Follicle stimulating hormone (natural FSH from all species and their synthetic analogues)	All food-producing species
Formaldehyde	All food-producing species
Formic acid	All food-producing species
Glutaraldehyde	All food-producing species
Guaiacol	All food-producing species
Heparin and its salts	All food-producing species
Human chorionic gonadotropin (natural HCG and its synthetic analogues)	All food-producing species
Iron ammonium citrate	All food-producing species
Iron dextran	All food-producing species
Iron glucoheptonate	All food-producing species
Isopropanol	All food-producing species
Lanolin	All food-producing species
Luteinising hormone (natural LH from all species and their synthetic analogues)	All food-producing species
Magnesium chloride	All food-producing species
Magnesium gluconate	All food-producing species
Magnesium hypophosphite	All food-producing species
Mannitol	All food-producing species
Methylbenzoate	All food-producing species
Monothioglycerol	All food-producing species
Montanide	All food-producing species
Myglyol	All food-producing species
Orgotein	All food-producing species
Poloxalene	All food-producing species
Poloxamer	All food-producing species
Polyethylene glycols (molecular weight ranging from 200 to 10000)	All food-producing species
Polysorbate 80	All food-producing species
Serotonin	All food-producing species
Sodium chloride	All food-producing species
Sodium cromoglycate	All food-producing species
Sodium dioctylsulphosuccinate	All food-producing species
Sodium formaldehydesulphoxylate	All food-producing species
Sodium lauryl sulphate	All food-producing species
Sodium pyrosulphite	All food-producing species
Sodium stearate	All food-producing species
Sodium thiosulphate	All food-producing species
Tragacanth	All food-producing species
Urea	All food-producing species
Zinc oxide	All food-producing species
Zinc sulphate	All food-producing species
Adenosine and its 5′-mono-, 5′-di- and 5′-triphosphates	All food producing species
Alanine	All food producing species
Arginine	All food producing species
Asparagine	All food producing species
Aspartic acid	All food producing species
Carnitine	All food producing species
Choline	All food producing species
Chymotrypsin	All food producing species
Citrulline	All food producing species
Cysteine	All food producing species
Cytidine and its 5′-mono-, 5′-di- and 5′-triphosphates	All food producing species
Glutamic acid	All food producing species
Glutamine	All food producing species
Glycine	All food producing species
Guanosine and its 5′-mono-, 5′-di- and 5′-triphosphates	All food producing species
Histidine	All food producing species
Hyaluronic acid	All food producing species
Inosine and its 5′-mono-, 5′-di- and 5′-triphosphates	All food producing species
Inositol	All food producing species
Isoleucine	All food producing species
Leucine	All food producing species
Lysine	All food producing species
Methionine	All food producing species
Ornithine	All food producing species
Orotic acid	All food producing species
Pepsin	All food producing species
Phenylalanine	All food producing species
Proline	All food producing species
Serine	All food producing species
Thioctic acid	All food producing species
Threonine	All food producing species
Thymidine	All food producing species
Trypsin	All food producing species
Tryptophan	All food producing species
Tyrosine	All food producing species
Uridine and its 5′-mono-, 5′-di- and 5′-triphosphates	All food producing species
Valine	All food producing species

4.Substances used in homeopathic veterinary medicinal products

Pharmacologically active substance(s)	Animal species	Other provisions
All substances used in homeopathic veterinary medicinal products provided that their concentration in the product does not exceed one part per ten thousand	All food-producing species
Adonis vernalis	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Acqua levici	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias only
Atropa belladonna	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Convallaria majalis	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only
Apocynum cannabinum	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred onlyFor oral use only
Harunga madagascariensis	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Selenicereus grandiflorus	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Thuja occidentalis	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Virola sebifera	All food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only
Ruta graveolens	All food-producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only.Not for use in animals from which milk is produced for human consumption
Aesculus hippocastanum	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per ten only
Agnus castus	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Ailanthus altissima	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Allium cepa	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Arnicae radix	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only
Artemisia abrotanum	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Bellis perennis	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Calendula officinalis	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only
Camphora	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per hundred only.
Cardiospermum halicacabum	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Crataegus	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Echinacea	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof onlyFor topical use only.For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only
Eucalyptus globulus	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Euphrasia officinalis	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Ginkgo biloba	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.
Ginseng	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Hamamelis virginiana	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per ten only
Harpagophytum procumbens	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Hypericum perforatum	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Lachnanthes tinctoria	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.
Lobaria pulmonaria	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Okoubaka aubrevillei	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Prunus laurocerasus	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.
Serenoa repens	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Silybum marianum	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Solidago virgaurea	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Syzygium cumini	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Turnera diffusa	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Viscum album	All-food producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Phytolacca americana	All food-producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only
Urginea maritima	All food-producing species	For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred onlyFor oral use only

5.Substances used as food additives in foodstuffs for human consumption

Pharmacologically active substance(s)	Animal species	Other provisions
Substances with an E number	All food-producing species	Only substances approved as additives in foodstuffs for human consumption, with the exception of preservatives listed in part C of Annex III to European Parliament and Council Directive 95/2/EC (OJ L 61, 18.3.1995, p. 1).

6.Substances of vegetable origin

Pharmacologically active substance(s)	Animal species	Other provisions
Aloe vera gel and whole leaf extract of Aloe vera	All food-producing species	For topical use only
Aloes, Barbados and Capae, their standardised dry extract and preparations thereof	All food-producing species
Angelicae radix aetheroleum	All food-producing species
Anisi aetheroleum	All food-producing species
Anisi stellati fructus, standardised extracts and preparations thereof	All food producing species
Arnica montana (arnicae flos and arnicae planta tota)	All food-producing species	For topical use only
Balsamum peruvianum	All food-producing species	For topical use only
Boldo folium	All food-producing species
Calendulae flos	All food-producing species	For topical use only
Capsici fructus acer	All food-producing species
Carlinae radix	All food-producing species	For topical use only
Carvi aetheroleum	All food-producing species
Caryophylli aetheroleum	All food-producing species
Centellae asiaticaer extractum	All food producing species	For topical use only
Chrysanthemi cinerariifolii flos	All food-producing species	For topical use only
Cimicifugae racemosae rhizoma	All food-producing species	Not for use in animals from which milk is produced for human consumptiom
Cinchonae cortex, standardised extracts and preparations thereof	All food producing species
Cinnamomi cassiae aetheroleum	All food-producing species
Cinnamomi cassiae cortex, standardised extracts and preparations thereof	All food producing species
Cinnamomi ceylanici aetheroleum	All food-producing species
Cinnamomi ceylanici cortex, standardised extracts and preparations thereof	All food producing species
Citri aetheroleum	All food-producing species
Citronellae aetheroleum	All food-producing species
Condurango cortex, standardised extracts and preparations thereof	All food producing species
Coriandri aetheroleum	All food-producing species
Cupressi aetheroleum	All food-producing species	For topical use only
Echinacea purpurea	All food-producing species	For topical use only
Eucalypti aetheroleum	All food-producing species
Foeniculi aetheroleum	All food-producing species
Frangulae cortex, standardised extracts and preparations thereof	All food producing species
Gentianae radix, standardised extracts and preparations thereof	All food producing species
Hamamelis virginiana	All food-producing species	For topical use only
Hippocastani semen	All food-producing species	For topical use only
Hyperici oleum	All food-producing species	For topical use only
Juniperi fructus	All food-producing species
Lauri folii aetheroleum	All food-producing species
Lauri fructus	All food-producing species
Lavandulae aetheroleum	All food-producing species	For topical use only
Lespedeza capitata	All food-producing species
Lini oleum	All food-producing species
Majoranae herba	All food-producing species
Matricaria recutita and preparations thereof	All food producing species
Matricariae flos	All food-producing species
Medicago sativa extractum	All food-producing species	For topical use only
Melissae aetheroleum	All food producing species
Melissae folium	All food-producing species
Menthae arvensis aetheroleum	All food-producing species
Menthae piperitae aetheroleum	All food-producing species
Millefolii herba	All food-producing species
Myristicae aetheroleum	All food-producing species	For use in newborn animals only
Oxidation products of Terebinthinae oleum	Bovine, porcine, ovine, caprine
Pyrethrum extract	All food-producing species	For topical use only
Quercus cortex	All food-producing species
Quillaia saponins	All food-producing species
Rhei radix, standardised extracts and preparations thereof	All food producing species
Ricini oleum	All food-producing species	For use as excipient
Rosmarini aetheroleum	All food-producing species
Rosmarini folium	All food-producing species
Ruscus aculeatus	All food-producing species	For topical use only
Salviae folium	All food-producing species
Sambuci flos	All food-producing species
Sinapis nigrae semen	All food-producing species
Strychni semen	Bovine, ovine, caprine	For oral use only at doses up to the equivalent of 0,1 mg strychnine/kg bw
Symphyti radix	All food-producing species	For topical use on intact skin only
Terebinthinae aetheroleum rectificatum	All food-producing species	For topical use only
Terebinthinae laricina	All food-producing species	For topical use only
Thymi aetheroleum	All food-producing species
Tiliae flos	All food-producing species
Urticae herba	All food-producing species

7.Anti-infectious agents

Pharmacologically active substance(s)	Animal species	Other provisions
Oxalic acid	Honey bees

ANNEX IIILIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED1.Anti-infectious agents1.1.Chemotheurapeutics1.1.2.Benzenesulphonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Clorsulon	Clorsulon	Bovine	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			150 μg/kg	Liver
			400 μg/kg	Kidney

1.2.Antibiotics1.2.1.Beta-lactamase inhibitors

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Clavulanic acid	Clavulanic acid	Bovine, ovine	200 μg/kg	Milk	Provisional MRLs expire on 1 July 2001
		Bovine, ovine, porcine	200 μg/kg	Muscle
			200 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney

1.2.2.Macrolides

Provisional MRLs expire on 1 July 2006.Not for use in animals from which eggs are produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Acetylisovaleryltylosin	Sum of acetylisovaleryltylosin and 3-O-acetyltylosin	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Skin and fat
			100 μg/kg	Liver
			100 μg/kg	Kidney
Acetylisovaleryltylosin	Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin	Poultry	50 μg/kg	Skin and fat
Acetylisovaleryltylosin	Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin	Poultry	50 μg/kg	Liver
Erythromycin	MRLs apply to all microbiological active residues expressed as erythromycin equivalent	Bovine, ovine	40 μg/kg	Milk	Provisional MRLs expire on 1 June 2000
		Bovine, ovine, porcine, poultry	400 μg/kg	Muscle
			400 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney
		Poultry	200 μg/kg	Eggs
Josamycin	Josamycin	Chicken	200 μg/kg	Muscle	Provisional MRLs expire on 1.7.2002
			200 μg/kg	Fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
			200 μg/kg	Eggs
	Sum of the microbiologically active metabolites, expressed as josamycin	Porcine	200 μg/kg	Muscle	Provisional MRLs expire on 1.7.2002
			200 μg/kg	Skin and fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
Tilmicosin	Tilmicosin	Bovine	40 μg/kg	Milk	Provisional MRLs expire on 1.1.2001
Tulathromycin	(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2- ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa- 6-azacyclopent-decan-15-one expressed as tulathromycin equivalents	Bovine	100 μg/kg	Fat	Provisional MRLs expire on 1 July 2004; not for use in animals from which milk is produced for human consumption
			3000 μg/kg	Liver
			3000 μg/kg	Kidney
		Porcine	100 μg/kg	Skin and fat	Provisional MRLs expire on 1 July 2004
			3000 μg/kg	Liver
			3000 μg/kg	Kidney

1.2.4.Cephalosporins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cefacetrile	Cefacetrile	Bovine	125 μg/kg	Milk	Provisional MRLs expire on 1.1.2002For intrammamary use only
Cefalonium	Cefalonium	Bovine	10 μg/kg	Milk	Provisional MRLs expire on 1.1.2003
Cefoperazone	Cefoperazone	Bovine	50 μg/kg	Milk	Provisional MRLs expire on 1 January 2001
Cefquinome	Cefquinome	Porcine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2000
			50 μg/kg	Skin + fat
			100 μg/kg	Liver
			200 μg/kg	Kidney
Cephapirin	Sum of cephapirin and desacetylcephapirin	Bovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			50 μg/kg	Liver
			100 μg/kg	Kidney
			10 μg/kg	Milk

1.2.5.Aminoglycosides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Aminosidine	Aminosidine	Bovine, porcine, rabbits, chicken	500 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
			1500 μg/kg	Liver
			1500 μg/kg	Kidney
Apramycin	Apramycin	Bovine	1000 μg/kg	Muscle	Provisional MRLs expire on 1 July 1999
		For use in non-lactating cattle only	1000 μg/kg	Fat
			10000 μg/kg	Liver
			20000 μg/kg	Kidney
		Porcine	1000 μg/kg	Muscle
			1000 μg/kg	Skin and fat
			1000 μg/kg	Liver
			5000 μg/kg	Kidney
Dihydrostreptomycin	Dihydrostreptomycin	Bovine, ovine	500 μg/kg	Muscle	Provisional MRLs expire on 1.6.2002
			500 μg/kg	Fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	500 μg/kg	Muscle
			500 μg/kg	Skin and fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
Gentamicin	Gentamicin	Bovine	100 μg/kg	Milk	Provisional MRLs expire on 1.6.2002
		Bovine, porcine	50 μg/kg	Muscle
			50 μg/kg	Fat
			200 μg/kg	Liver
			750 μg/kg	Kidney
Kanamycin	Kanamycin	Rabbits	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2004
			100 μg/kg	Fat
			600 μg/kg	Liver
			2500 μg/kg	Kidney
		Bovine, ovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			600 μg/kg	Liver
			2500 μg/kg	Kidney
			150 μg/kg	Milk
		Porcine, chicken	100 μg/kg	Muscle
			100 μg/kg	Skin + fat
			600 μg/kg	Liver
			2500 μg/kg	Kidney
Neomycin (including framycetin)	Neomycin B	Bovine, porcine, chicken	500 μg/kg	Muscle	Provisional MRLs expire on 1.6.2002
			500 μg/kg	Fat
			500 μg/kg	Liver
			5000 μg/kg	Kidney
		Bovine	500 μg/kg	Milk
		Chicken	500 μg/kg	Eggs
Spectinomycin	Spectinomycin	Bovine	200 μg/kg	Milk	Provisional MRLs expire on 1 July 2000
		Bovine, porcine, poultry	300 μg/kg	Muscle
			500 μg/kg	Fat
			2000 μg/kg	Liver
			5000 μg/kg	Kidney
		OvineNot for use in animals from which milk is produced for human consumption	300 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			500 μg/kg	Fat
			2000 μg/kg	Liver
			5000 μg/kg	Kidney
		Chicken	200 μg/kg	Eggs
Streptomycin	Streptomycin	Bovine, ovine	500 μg/kg	Muscle	Provisional MRLs expire on 1.6.2002
			500 μg/kg	Fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	500 μg/kg	Muscle
			500 μg/kg	Skin and fat
			500 μg/kg	Liver
			1000 μg/kg	Kidney

1.2.6.Quinolones

Provisional MRLs expire 1 January 2006.Not for use in animals from which milk is produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Danofloxacin	Danofloxacin	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2000
			50 μg/kg	Skin and fat
			200 μg/kg	Liver
			200 μg/kg	Kidney
Decoquinate	Decoquinate	Bovine, ovine	500 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
			500 μg/kg	Fat
			500 μg/kg	Liver
			500 μg/kg	Kidney
Difloxacin	Difloxacin	BovineNot for use in animals from which milk is produced for human consumption	400 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			100 μg/kg	Fat
			1400 μg/kg	Liver
			800 μg/kg	Kidney
		Porcine	400 μg/kg	Muscle
			100 μg/kg	Skin and fat
			800 μg/kg	Liver
			800 μg/kg	Kidney
Enrofloxacin	Sum of enrofloxacin and ciprofloxacin	Ovine	100 μg/kg	Muscle	Provisional MRLs expire on 1 July 1999
			100 μg/kg	Fat
			300 μg/kg	Liver
			200 μg/kg	Kidney
Flumequine	Flumequine	Bovine, ovine, porcine, chicken	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			50 μg/kg	Fat or skin and fat
			100 μg/kg	Liver
			300 μg/kg	Kidney
		Salmonidae	150 μg/kg	Muscle and skin
Marbofloxacin	Marbofloxacin	Bovine	150 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
			50 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
			75 μg/kg	Milk
		Porcine	150 μg/kg	Muscle
			50 μg/kg	Skin and fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
Oxolinic acid	Oxolinic acid	Bovine	100 µg/kg	Muscle
			50 µg/kg	Fat
			150 µg/kg	Liver
			150 µg/kg	Kidney
		Porcine	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
		Chicken	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
			50 μg/kg	Eggs
		Fin fish	300 μg/kg	Muscle and skin in natural proportions

1.2.9.Polymyxins

Phamarcologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Colistin	Colistin	Bovine, ovine	50 μg/kg	Milk	Provisional MRLs expire on 1.7.2002
		Bovine, ovine, porcine, chicken, rabbits	150 μg/kg	Muscle
			150 μg/kg	Fat
			150 μg/kg	Liver
			200 μg/kg	Kidney
		Chicken	300 μg/kg	Eggs

1.2.10.Penicillins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Nafcillin	Nafcillin	Bovine	300 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney
			30 μg/kg	Milk
Penethamate	Benzylpenicillin	Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			4 μg/kg	Milk
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney

1.2.11.Florfenicol and related compounds

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Florfenicol	Sum of florfenicol and its metabolites measured as florfenicol-amine	Fish	1000 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 July 2001
Thiamphenicol	Thiamphenicol	Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Fin fish	50 μg/kg	Muscle and skin in natural proportions

1.2.12.Polypeptides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Bacitracin	Bacitracin	Bovine	150 μg/kg	Milk	Provisional MRLs expire on1.7.2001

1.2.13.Lincosamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Lincomycin	Lincomycin	Ovine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			500 μg/kg	Liver
			1500 μg/kg	Kidney
			150 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			500 μg/kg	Liver
			1500 μg/kg	Kidney
		Chicken	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			500 μg/kg	Liver
			1500 μg/kg	Kidney
			50 μg/kg	Eggs
Pirlimycin	Pirlimycin	Bovine	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2000
			100 μg/kg	Fat
			1000 μg/kg	Liver
			400 μg/kg	Kidney
			100 μg/kg	Milk

1.2.14.Pleuromutilines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Tiamulin	Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin	Turkey	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Skin and fat
			300 μg/kg	Liver

2.Antiparasitic agents2.1.Agents acting against endoparasites2.1.1.Phenol derivatives including salicylanides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Oxyclozanide	Oxyclozanide	Bovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2002
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney
			10 μg/kg	Milk
		Ovine	20 μg/kg	Muscle
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney

2.1.2.Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Albendazole sulphoxide	Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole	Bovine, ovine	100 μg/kg	Milk	Provisional MRLs expire on 1 January 2000
		Bovine, ovine, pheasant	100 μg/kg	Muscle
			100 μg/kg	Fat
			1000 μg/kg	Liver
			500 μg/kg	Kidney
Mebendazole	Sum of mebendazole methyl (5-(1-hidroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents	Ovine, caprine, equidaeNot for use in animals from which milk is produced for human consumption	60 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			60 μg/kg	Fat
			400 μg/kg	Liver
			60 μg/kg	Kidney
Netobimin	Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone	Bovine, ovine, caprine	100 μg/kg	Muscle	Provisional MRLs expire on 31 July 1999
			100 μg/kg	Fat
			1000 μg/kg	Liver
			500 μg/kg	Kidney
			100 μg/kg	Milk

2.1.3.Tetrahydropyrimides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Morantel	Sum of residues which may be hydrolysed to N-Methyl-1,3-propanediamine and expressed as morantel equivalents	Bovine, ovine	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003
			100 μg/kg	Fat
			800 μg/kg	Liver
			200 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			800 μg/kg	Liver
			200 μg/kg	Kidney

2.1.5.Piperazine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Piperazine	Piperazine	Porcine	400 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003
			800 μg/kg	Skin and fat
			2000 μg/kg	Liver
			1000 μg/kg	Kidney
		Chicken	2000 μg/kg	Eggs

2.1.6.Salicylanilides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Rafoxanide	Rafoxanide	BovineNot for use in animals from which milk is produced for human consumption	30 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			30 μg/kg	Fat
			10 μg/kg	Liver
			40 μg/kg	Kidney
		OvineNot for use in animals from which milk is produced for human consumption	100 μg/kg	Muscle
			250 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney

2.2.Agents acting against ectoparasites2.2.1.Formamidines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Amitraz	Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz	Bees	200 μg/kg	Honey	Provisional MRLs expire on 1 July 1999

2.2.2.Iminophenyl thiazolidine derivative

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cymiazole	Cymiazole	Bees	1000 μg/kg	Honey	Provisional MRLs expire on 1.7.2001

2.2.3.Pyretrin and pyrethroids

Provisional MRLs expire on 1 July 2006.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyfluthrin	Cyfluthrin	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1 January 2001
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
				Further provisions in Council Directive 94/29/EC are to be observed (OJ L 189, 23.7.1994, p. 67)
Alphacypermethrin	Cypermethrin (sum of isomers)	Bovine, ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003Further provisions in Directive 93/57/EC are to be observed
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	MilkFurther provisions in Council Directive 93/57/EC (OJ L 211, 23.8.1992, p. 1) are to be observed
		Chicken	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Eggs
Cypermethrin	Cypermethrin (sum of isomers)	Bovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003Further provisions in Directive 93/57/EC are to be observed
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk
	Cypermethrin (sum of isomers)	Ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003Not for use in animals from which milk is produced for human consumption
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		Porcine	20 μg/kg	Muscle
			200 μg/kg	Skin + fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		Chicken	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Eggs
		Salmonidae	50 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.7.2003
Deltamethrin	Deltamethrin	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1 July 2001
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
		OvineNot for use in animals from which milk is produced for human consumption	10 μg/kg	Muscle
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
		Chicken	10 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003
			50 μg/kg	Skin + fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			50 μg/kg	Eggs
		Fin fish	10 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.1.2002
Fenvalerate	Fenvalerate (sum of RR, SS, RS and SR isomers)	Bovine	25 μg/kg	Muscle
			250 μg/kg	Fat
			25 μg/kg	Liver
			25 μg/kg	Kidney
			40 μg/kg	Milk
Permethrin	Permethrin (sum of isomers)	Chicken, porcine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2003
			500 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Bovine, caprine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2003
			500 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk	Further provisions in Commission Directive 98/82/EC are to be observed (OJ L 290, 29.10.1998, p. 25)
		Chicken	50 μg/kg	Eggs	Provisional MRLs expire on 1.1.2003

2.2.4.Organophosphates

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Azamethiphos	Azamethiphos	Salmonidae	100 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 June 1999
Coumafos	Coumafos	Bees	100 μg/kg	Honey	Provisional MRLs expire on 1.7.2001
Phoxim	Phoxim	Porcine	20 μg/kg	Muscle	Provisional MRLs expire on 1 January 2001
			700 μg/kg	Skin and fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001; not for use in animals from which milk is produced for human consumption
			400 μg/kg	Fat
			50 μg/kg	Kidney
		Chicken	50 μg/kg	Muscle	Provisional MRLs expire on 1.7.2005.
			550 μg/kg	Skin and fat
			25 μg/kg	Liver
			50 μg/kg	Kidney
			60 μg/kg	Eggs
Propetamphos	Sum of residues of propetamphos and desisopropyl-propetamphos	OvineNot for use in animals from which milk is produced for human consumption	90 μg/kg	Fat	Provisional MRLs expire on 1.1.2001
Propetamphos			90 μg/kg	Kidney	Provisional MRLs expire on 1.1.2001

2.2.5.Acyl urea derivates

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Teflubenzuron	Teflubenzuron	Salmonidae	500 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 July 1999
Diflubenzuron	Diflubenzuron	Salmonidae	1000 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.7.2000

2.2.6.Pyrimidines derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Dicyclanil	Sum of dicyclanil and 2,4,6-triamino-pyrimidine-5-carbonitrile	Ovine	200 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000;Not for use in animals from which milk is produced for human consumption
			50 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney

2.2.7.Triazine derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyromazine	Cyromazine	Ovine	300 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001Not for use in animals from which milk is produced for human consumption
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney

2.3.Agents acting against endo- and ectoparasites2.3.1.Avermectins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Abamectin	Avermectin B1a	Ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			25 μg/kg	Liver
			20 μg/kg	Kidney
Doramectin	Doramectin	Deer, inclusing reindeer	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Fat
			50 μg/kg	Liver
			30 μg/kg	Kidney
Moxidectin	Moxidectin	Equidae	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			500 μg/kg	Fat
			100 μg/kg	Liver
			50 μg/kg	Kidney

2.4.Agents acting against protozoa2.4.1.Carbanilides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Imidocarb	Imidocarb	Bovine, ovine	300 μg/kg	Muscle	Provisonal MRLs expire on 1.1.2002
			50 μg/kg	Fat
			2000 μg/kg	Liver
			1500 μg/kg	Kidney
			50 μg/kg	Milk

2.4.2.Quinazolone derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Halofuginone	Halofuginone	Bovine	10 μg/kg	Muscle	Provisional MRL's expire on 1.1.2001
			25 μg/kg	Fat
			30 μg/kg	Liver
			30 μg/kg	Kidney

2.4.3.Triazinetrione derivatives

Provisional MRLs expire on 1 July 2006. Not for use in animals from which milk is produced for human consumption.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Toltrazuril	Toltrazuril sulfone	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			150 μg/kg	Skin and fat
			500 μg/kg	Liver
			250 μg/kg	Kidney
Toltrazuril	Toltrazuril sulfone	Bovine	100 μg/kg	Muscle
			150 μg/kg	Fat
			500 μg/kg	Liver
			250 μg/kg	Kidney

2.4.4.Other anti-protozoal agents

Pharmacologically active substance(s)	Marker residue	Animal species	MRL	Target tissues	Other provisions
Amprolium	Amprolium	Chicken, turkey	200 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			200 μg/kg	Skin and fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
			1000 μg/kg	Eggs

3.Agents acting on the nervous system3.2.Agents acting on the autonomic nervous system3.2.1.β 2 sympathomimetic agents

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Clenbuterol hydrochloride	Clenbuterol	Bovine	0,1 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
		Indication: solely for tocolysis in parturient cows	0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
			0,05 μg/kg	Milk
		Equidae	0,1 μg/kg	Muscle
		Indications: tocolysis and the treatment of respiratory ailments	0,5 μg/kg	Liver
			0,5 μg/kg	Kidney

3.2.2.Anti-adrenergics

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Carazolol	Carazolol	Bovine	5 μg/kg	Muscle	Provisional MRLs expire on 1.1.2000
			5 μg/kg	Fat
			15 μg/kg	Liver
			15 μg/kg	Kidney
			1 μg/kg	Milk

5.Anti-inflammatory agents5.1.Nonsteroidal anti-inflammatory agents5.1.1.Arylpropionic acid derivative

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Carprofen	Carprofen	Bovine	500 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			500 μg/kg	Fat
			1000 μg/kg	Liver
			1000 μg/kg	Kidney
		Equidae	50 μg/kg	Muscle
			100 μg/kg	Fat
			1000 μg/kg	Liver
			1000 μg/kg	Kidney

5.1.2.Enolic acid derivates

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Meloxicam	Meloxicam	Bovine	25 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			60 μg/kg	Liver
			35 μg/kg	Kidney

5.1.3.Pyrazolone derivatives

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Metamizole	4-Methylaminoantipyrin	Bovine, porcine, equidae	200 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003.Not for use in animals from which milk is produced for human consumption
			200 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney

6.Agents acting on the reproductive system6.1.Progestogens

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Altrenogest	Altrenogest	Porcine	3 μg/kg	Skin and fat	Provisional MRLs expire on 1.1.2005; for zootechnical use only
			3 μg/kg	Liver
			3 μg/kg	Kidney
		Equidae	3 μg/kg	Fat
			3 μg/kg	Liver
			3 μg/kg	Kidney
Flugestone acetate	Flugestone acetate	Ovine, caprine	0,5 μg/kg	Muscle	Provisional MRLs expire on 1.1.2008; for therapeutic or zootechnical use only
			0,5 μg/kg	Fat
			0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
Norgestomet	Norgestomet	Bovine	0,5 μg/kg	Muscle	Provisional MRLs expire on 1.1.2008; for therapeutic or zootechnical use only
			0,5 μg/kg	Fat
			0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
			0,15 μg/kg	Milk

7.Corticoids7.1.Glucocorticoids

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Methylprednisolone	Methylprednisolone	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001. Not for use in animals from which milk is produced for human consumption
			10 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney

ANNEX IVLIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH NO MAXIMUM LEVELS CAN BE FIXED

Pharmacologically active substance(s)
Aristolochia spp. and preparations thereof
Chloramphenicol
Chloroform
Chlorpromazine
Colchicine
Dapsone
Dimetridazole
Metronidazole
Nitrofurans (including furazolidone)
Ronidazole

ANNEX VInformation and particulars to be included in an application for the establishment of a maximum residue limit for a pharmacologically active substance used in veterinary medicinal productsAdministrative particulars1Name or corporate name and permanent address of the applicant.2Name of the veterinary medicinal product.3Qualitative and quantitative composition in terms of active principles, with mention of the international non-proprietary name recommended by the World Health Organization, where such name exists.4Manufacturing authorization, if any.5Marketing authorization, if any.6Summary of the characteristics of the veterinary medicinal product(s) prepared in accordance with Article 5a of Directive 81/851/EEC.A.Safety documentationA.0.Expert reportA.1.Precise identification of the substance concerned by the application1.1International non-proprietary name (INN).1.2International Union of Pure and Applied Chemistry (IUPAC) name.1.3Chemical Abstract Service (CAS) name.1.4Classification:therapeutic;pharmacological.1.5Synonyms and abbreviations.1.6Structural formula.1.7Molecular formula.1.8Molecular weight.1.9Degree of impurity.1.10Qualitative and quantitative composition of impurities.1.11Description of physical properties:melting point;boiling point;vapour pressure;solubility in water and organic solvents, expressed in grams per litre, with indication of temperature;density;refractive index, rotation, etc.A.2.Relevant pharmacological studies2.1Pharmacodynamics.2.2Pharmacokinetics.A.3.Toxicological studies3.1Single dose toxicity.3.2Repeated dose toxicity.3.3Tolerance in the target species of animal.3.4Reproductive toxicity, including teratogenicity.3.4.1Study of the effects on reproduction.3.4.2Embryotoxicity/fetotoxicity, including teratogenicity.3.5Mutagenicity.3.6Carcinogenicity.A.4.Studies of other effects4.1Immunotoxicity.4.2Microbiological properties of residues.4.2.1On the human gut flora;4.2.2On the organisms and microorganisms used for industrial food-processing.4.3Observations in humans.B.Residue documentationB.0Expert reportB.1.Precise identification of the substance concerned by the applicationThe substance concerned should be identified in accordance with point A.1. However, where the application relates to one or more veterinary medicinal products, the product itself should be identified in detail, including:qualitative and quantitative composition;purity;identification of the manufacturer's batch used in the studies; relationship to the final product;specific activity and radio-purity of labelled substances;position of labelled atoms on the molecule.B.2.Residue studies2.1Pharmacokinetics(absorption, distribution, biotransformation, excretion).2.2Depletion of residues.2.3Elaboration of maximum residue limits (MRLS).B3.Routine analytical method for the detection of residues3.1Description of the method.3.2Validation of the method.3.2.1specificity;3.2.2accuracy, including sensitivity;3.2.3precision;3.2.4limit of detection;3.2.5limit of quantitation;3.2.6practicability and applicability under normal laboratory conditions;3.2.7susceptibility to interference.